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Abstract
Systems Metabolic Engineering of Microbial Cell Factories for the
Synthesis of Value-added Chemicals
by
Arul Mozhy Varman
Doctor of Philosophy in Energy, Environmental, and Chemical Engineering
Washington University in St. Louis, 2013
Professor Yinjie J. Tang, Chair

Microbial cell factories offer us an excellent opportunity for the conversion of many
different cheaply available raw materials into valuable chemicals. Systems metabolic
engineering aims at developing rational strategies for the engineering of microbial hosts by
providing global level information of a cell. This dissertation focuses on metabolic engineering,
bioprocess modeling and pathway analysis, to develop robust microbial cell factories for the
synthesis of value-added chemicals. The following research tasks were completed in this regard.
First, statistical models were developed for the prediction of product yields in engineered
microbial cell factories - Saccharomyces cerevisiae and Escherichia coli (Chapter 2). A large
space of experimental data for chemical production from recent references was collected and a
statistics-based model was developed to calculate production yield. The input variables
(numerical or categorical variables) for the model represented the number of enzymatic steps in
the biosynthetic pathway of interest, metabolic modifications, cultivation modes, nutrition and
oxygen availability. In addition, the use of 13C-isotopomer analysis method was proposed for the
accurate determination of product yields in engineered microbes under complex cultivation
conditions (Chapter 3).
xiii

Second, metabolic engineering of the cyanobacterium, Synechocystis sp. PCC 6803 was
performed for synthesizing isobutanol under phototrophic conditions (Chapter 4). With the
expression of the heterologous genes from the Ehrlich Pathway, by incorporating an in situ
isobutanol harvesting system, and also by employing mixotrophic conditions, the engineered
Synechocystis 6803 strain accumulated a maximum of ~300 mg/L of isobutanol in a 21 day
culture. In addition, Synechocystis 6803 was engineered for the synthesis of D-lactic acid
(Chapter 5), via overexpression of a novel D-lactate dehydrogenase (encoded by gldA101). The
production of D-lactate was further improved by employing three strategies: (i) cofactor
balancing, (ii) codon optimization, and (iii) process optimization. The engineered Synechocystis
6803 produced 2.2 g/L D-lactate under photoautotrophic conditions with acetate, the highest
reported lactate titer among all known cyanobacterial strains.
Finally, an E. coli cell factory was engineered to study the fermentation kinetics for
scaled-up isobutanol production (Chapter 6).

Through kinetic modeling (to describe the

dynamics of biomass, products and glucose concentration) and isotopomer analysis, we have also
offered metabolic insights into the performance trade-off between two engineered isobutanol
producing E. coli strains (a high performance and a low performance strain). The kinetic model
can also predict isobutanol production under different fermentation conditions. I and my
colleagues have also demonstrated that E. coli cell factory can also be used for converting waste
acetate into free fatty acids through metabolic engineering. In conclusion, the opportunities and
commercial limitations with current biotechnology as well as the role of systems metabolic
engineering for the development of high performance microbial cell factories were discussed
(Chapter 7).

xiv

Chapter 1: Introduction to systems metabolic engineering of
microbial cell factories
1.1 Introduction
Biomass-derived carbon and energy have been used by human society for a long time.
This dependence was shifted to petroleum derived carbon and energy in recent times. A 2008
census indicated that most of the energy utilized worldwide came from the burning of fossil fuels
and it accounted for about 80% of the energy consumed1. The U.S. Energy Information
Administration had projected a 49% increase in global energy demand from 2007 to 20352. This
dependence on fossil fuels cannot go on forever as oil reserves have started dwindling.
Furthermore, the USEPA reports that the atmospheric CO2 concentrations has increased by up to
35% since the industrial revolution in the 1700’s3, while CO2 produced from burning fossil fuels
contributed to about 56.6% (2004 data) of the total greenhouse gas emissions3. In consideration
of the energy security and environmental concerns there is a growing need for the production of
biofuels and petroleum-derived chemicals from renewable sources.
For the production of chemicals from microbes to be economical, the target chemical
must be produced at high yield, titer and productivity. These traits are difficult to be met by
naturally occurring microbes4. Henceforth, microbes must be engineered to achieve the desired
traits. With the advent of recombinant DNA technology, we now have the tools to redesign
metabolic pathways for the production of chemicals from renewable materials. Technologies
beyond simple genetic engineering are often required to achieve a desired phenotype and much
of this rational modification has been performed in the form of metabolic engineering. Metabolic
engineering is the improvement of cellular activities by manipulation of enzymatic, transport,
1

and regulatory functions of the cell by the application of recombinant DNA technology5. On the
other hand, systems biology Metabolic engineering can be integrated with systems analysis and
modeling to perform rational engineering of microbial hosts6.

1.2 Microbial cell factories
Microbial biocatalysts offer several advantages in producing small-molecule chemicals.
Unlike conventional chemical syntheses which are heavily dependent on petroleum-derived
substrates, microbes are able to use renewable materials to synthesize many commodity
chemicals and fuels7. Due to its scalability, microorganisms are also suitable platforms to
synthesize pharmaceutical molecules. Among the many industrial microorganisms, Escherichia
coli and Saccharomyces cerevisiae have long been the industrial workhorses preferred for
metabolic engineering applications. These two organisms have well-established genetic tools
and have been explored to create industrial scale production of chemicals from microbes8.
Developments in genetic tools have led to the ability to efficiently engineer E. coli as a
biocatalyst for the production of a wide variety of chemicals, potential biofuels and
pharmaceuticals9. S. cerevisiae is typically known for its robustness in fermenting sugars into
alcohol. It has also gained importance as a heterologous platform to synthesize many precursors
of commodity chemicals and pharmaceuticals 7.
Sugars (such as glucose, xylose starch, and sucrose) have been widely used for biofuel
production, which can be obtained either from food crops (corn, sugarcane, sugar beet) or from
biomass polymers (i.e., cellulose and hemicellulose). To reduce feedstock costs, a great deal of
effort has been focused on the isolation, characterization and engineering of a handful of species
(e.g., Clostridium thermocellum and Clostridium phytofermentans) that can utilize cheap
2

biomass for bioproduct synthesis (such as ethanol)8. Engineered Clostridium cellulolyticum has
been shown to produce isobutanol directly from crystalline cellulose10. More recently, E. coli
was engineered for the production of biodiesel directly from hemicelluloses, a plant derived
biomass11. Utilizing non-sugar-based substrates, such as glycerol, lactate, acetate, CO2, and
syngas (CO, CO2 and H2), for the production of value added chemicals has been a trend in recent
years (Figure 1.1).

Figure 1.1: Metabolic engineering pathways for biofuel production

Ethanol is currently the most commercially successful biofuel and can be produced by
yeast fermentations. Yeast efficiently converts sugar into ethanol and CO2 via glycolysis pathway
and pyruvate decarboxylase / alcohol dehydrogenase. Biofuels with properties similar to those of
3

gasoline and diesel fuel are being synthesized by microorganisms (Figure 1.1). Several
engineered biofuel pathways are being examined. For example, engineered Escherichia coli can
use the keto acid pathway and the Ehrlich pathway to produce higher alcohols (such as
isobutanol), while the mevalonate pathway in yeast can be extended to synthesize branched and
cyclic hydrocarbons (the biofuels with lower freezing point and higher energy content).
Table 1.1: Commonly employed microbes for biofuel production
Species

Substrates

Products

Features

Saccharomyces
cerevisiae

Glucose, fructose,
galactose, and
others

Alcohols

Easy genetic
manipulations, Crabtree
effect

Zymomonas
mobilis

Glucose, fructose,
sucrose

Ethanol

High ethanol tolerance and
yield

Clostridium
thermocellum

Glucose, cellulose,
cellobiose

Ethanol

Growth at high
temperature, mixed
fermentation pathways

Clostridium
acetobutylicum

Glucose, xylose

Ethanol and
butanol

Acetone, ethanol, and
butanol fermentation

Escherichia coli

Glucose, xylose,
Alcohols, diesels,
glycerol, and others and other biofuels

Easy genetic
manipulations, fast growth

Cyanobacteria
(e.g., Synechocystis
6803)

CO2

Alcohols, H2, fatty
acids

CO2 fixation

Phanerochaete
chrysosporium

Glucose and lignin

cellulosicbiomass
pretreatment

Strong ability to degrade
lignin

Yarrowia lipolytica

Glucose, acetate
and fatty acids

Lipids

Oleaginous yeast that
accumulates lipids

Finally, microbial metabolisms for biofuel production are very different across the
species. Saccharomyces cerevisiae and Escherichia coli are microbial cell factories that are
widely used in biofuel industrial because the two model species ferment sugar efficiently and are
4

also amenable to genetic modification and bioprocess scale up. Other microbial species, such as
cyanobacteria, are also promising hosts for biofuel production because they can convert sunlight
and CO2 to biomass and products. The species diversity in metabolic features offers opportunity
for synthesizing many different useful products from diverse carbon substrates. Table 1.1 shows
several different microbial species that produce biofuels, either via the native biofuel pathway or
via a metabolically engineered pathway.

1.3 Tools for genetic engineering of microbial hosts
Overexpression of native or heterologous genes is often achieved through plasmid based
expression systems. Plasmids are naked DNA molecules that are capable of replication within
the host. Plasmids are commonly used to carry genetic materials and transfer them to the
microbial host. The gene expression is mainly controlled at the transcript level, i.e., by tuning
with the promoter. The most widely used promoters are the lac and the hybrid promoters such as
tac, tic and trc.

These promoters can be induced under the presence of isopropyl-β-D-

thiogalactopyranoside (IPTG).

However, there is also research being done for the use of

constitutive promoters for gene expression. Some of them rely on the use of natural promoters
and others rely on random mutation of constitutive promoters. One of the goals of synthetic
biology is to manipulate protein expression at the translation level and this can be achieved by
modulation of the ribosomal binding site. Riboregualtors have been developed to tune gene
expression by RNA-RNA interactions. Another method by which gene targets can be
overexpressed is through codon optimization4.
Plasmid based expression systems often suffer from unstable genetic performance.
Chromosomal integration of target genes along with the promoter can be utilized to avoid this
5

problem. Often, overexpression of many genes would be required to achieve a desired yield.
Novel approaches have been developed to control the coordinated expression of each gene. One
such approach combines multiple genes into an operon under the control of a single promoter
and the expression of each gene is controlled at posttranscriptional stage by tuning the intergenic
regions.

This method was applied for the coordinated expression of three genes of the

heterologous mevalonate pathway in E. coli and resulted in an increase of the mevalonate
production by sevenfold 12.
Knockout of competing pathways can redirect the flux of carbon towards the product of
interest. Gene deletion is often achieved through homologous recombination and traditionally
this is performed through plasmids containing a selectable marker flanked by DNA fragments of
the target gene. Genes can be deleted in yeast by the use of a linear PCR fragment along with a
short flanking region homologous to the target DNA. Gene deletions can also be performed
using bacteriophage, and they depend on the FLP-FRP recombination to remove the marker after
gene deletion. This method leaves a 68bp FRT scar on the chromosome for each deletion
performed.

1.4 Cyanobacteria as a microbial cell factory
Direct capture of CO2 for the synthesis of bioproducts is a more economical and
environmental friendly approach that has received extensive studies recently. Cyanobacteria or
blue-green algae are photoautotrophic prokaryotes and can fix CO2 in the presence of sunlight.
The photosynthetic efficiency of cyanobacteria is much higher than that of higher plants (10 –
20% in contrast to 0.5% in higher plants)1. The transformability of some cyanobacteria species
coupled with the availability of sequenced genomes allows us to perform complex genetic
6

engineering13. They generally have high growth rates as compared to green algae and plants.
The diversity of metabolic capability in cyanobacteria lets them grow in highly saline
environments as well as marginal lands and hence will not compete with land used for
agriculture14.

Among all cyanobacterial species, Synechocystis sp. PCC 6803 (hereafter

Synechocystis 6803) is one of the most extensively studied species since it was initially isolated
from a freshwater lake in 1968. The entire genome, including four endogenous plasmids, was
sequenced in 1996, and over 3000 genes have been annotated to date15, 16. Synechocystis 6803
demonstrates versatile carbon metabolisms, growing under photoautotrophic, mixotrophic and
heterotrophic conditions 17. Additionally, biochemical similarities between the plant chloroplasts
and Synechocystis 6803 make the latter an ideal system for studying the molecular mechanisms
underlying stress responses and stress adaptation in higher plants18. More importantly, this
species is naturally competent (homologous recombination at high frequency)19. The recent
developments in synthetic biology have provided plenty of molecular biology tools to engineer
Synechocystis 6803 as a photosynthetic host for the production of diverse types of chemicals.
Metabolic engineering has been applied for microbial ethanol production, including
overexpression of genes to increase ethanol yield, disruption of genes to direct the carbon flux to
ethanol and deletion of enzymes that can oxidize NADH. To directly convert CO2 to biofuel, the
cyanobacterium Synechococcus sp. PCC 7002 was engineered for the synthesis of ethanol

20

.

Recently, pdc and adh genes from Zymomonas mobilis were integrated into the chromosome of
Synechocystis sp. PCC6803 under the control of the strong light driven psbA2 promoter. An
average yield of 5.2 mmol ethanol OD730 unit-1 litre-1 day-1 was achieved

21

. Algenol Biofuels

Inc. claim that they can produce ethanol at a rate of 6000 gal/acre/year from an engineered
cyanobacterial strain22.
7

Butanol is hydrophobic, has greater energy density, and a higher octane rating relative to
ethanol. Therefore, butanol biosynthesis has received extensive studies. Acetone-butanol-ethanol
(ABE) fermentation uses Clostridium acetobutylicum to produce n-butanol, but such process is
restrained by relatively low production rate and generates large amount of byproducts. To
overcome this problem, the n-butanol pathway derived from Clostridium was reconstructed in
fast-growing E. coli or yeast strains

23, 24

. Another novel alcohol synthesis approach is via non-

fermentative pathway25, where the amino acids biosynthesis pathways and Ehrlich pathway 26, 27
were utilized to convert glucose to alcohols. Cyanobacteria have been explored for biofuel
production (Figure 1.2). Synechococcus elongatus PCC 7942 was engineered to accumulate 450
mg/L of isobutanol in 6 days28. S. elongatus 7942 was engineered with a modified CoAdependent 1-butanol pathway and this strain accumulated 14.5 mg/L 1-butanol under anoxic
condition29. Long chain alcohols and hydrocarbons have ideal properties for combustion and are
found to be either additives or major components of petroleum.

Synechocystis 6803 and

Arabidospis thaliana were engineered with a heterologous fatty acyl-CoA reductase (FAR) for
the production of fatty alcohols30. Researchers at LS9 identified two key enzymes responsible
for the production of alkanes in cyanobacteria: an acyl-CoA carboxylase and an aldehyde
decarbonylase

31

. This discovery opens up many possibilities for engineering cyanobacteria for

alkane production.

8

Figure 1.2: Schematic representation of engineered biochemical pathways for the production of
biofuels in cyanobacteria. Abbreviations: RuBP, Ribulose-1,5-bisphosphate3-PGA; 3phosphoglycerate; Kdc, ketoacid decarboxylase; ADH, alcohol dehydrogenase; PDC , pyruvate
decarboxylase; ACC, acetyl-CoA carboxylase; AAR, acyl-ACP reductase; AAD, aldehyde
decarbonylase; FAR, fatty acyl-CoA reductase; Ter, trans-2-enoyl-CoA reductase; Hbd, 3hydroxybutyryl-CoA dehydrogenase; AdhE2, aldehyde/alcoholdehydrogenase; LDH, lactate
dehydrogenase; EFE, Ethylene formation enzyme. Highlighted reactions indicate the pathway
that will be focused in this study.

Finally, many of the cyanobacterial strains have native hydrogenases that can evolve
hydrogen under anoxic conditions. Though the theoretical efficiency for hydrogen production is
predicted to be high, the efficiency in which wild type cyanobacterial strains produce hydrogen
was observed to be very low (< 0.1%)

13

. Synechococcus elongatus sp. 7942 was engineered

with hydrogenase from Clostridium acetobutylicum and was demonstrated that the
9

heterogeneous hydrogenase can support hydrogen evolution at a rate >500 times than that of
endogenous hydrogenase under anoxic conditions32.

1.5 Modeling and Systems Analysis
Mathematical kinetic models can be helpful in interpreting experimental data, in
understanding quantitative functions of biological systems, and in predicting metabolic
performances

33

. Arnold Fredrickson introduced the terms “segregated” and “structured” to

categorize most kinetic models for biological systems. The term “segregated” was used to take
into account the presence of heterogeneous individuals in a cell population explicitly (For
example: a model that would take into account the different age groups of cell that would be
present in a cell population). The “structured” kinetic model was used to define formulation of
cell systems as composed of multiple biomass components. The group “Unsegregated and
unstructured” is the most idealized case which considers the cell population as one component
solute and most of the kinetic models will fall in this category (e.g., Michaelis-Menten kinetics:
V=Vm×S/(Km+S) 34).
On the other hand, metabolic fluxes do not consider kinetic behavior of microorganisms,
but they provide the ratios in which each pathway is engaged in cellular functions. Fluxomics in
an organism were first studied using in silico analysis known as Flux Balance Analysis (FBA).
FBA uses the stoichiometry of metabolic reactions along with a set of constraints34. The total
number of reactions and constraints is often less than the number of variables (Flux) to be
calculated and hence the system is underdetermined. This necessitates the use of an objective
function to calculate the set of theoretical fluxes. Maximization of biomass is the objective
function employed generally as all species evolve themselves to multiply more in their
10

environment.

13

C-MFA computes the overall pathway activities in an organism by utilizing the

isotopic labeling approach and is valid only at isotopic and metabolic steady state.
performed by feeding the microbes with a

13

13

C-MFA is

C labeled carbon source followed by measurement

of the enrichment pattern of the metabolites. The isotopic labeling pattern of all the metabolites
is then fed to an algorithm to generate the intracellular fluxes34. Though both the methods of
FBA and

13

C-MFA utilize the overall metabolic network and use the assumption of metabolic

steady state, they have two different purposes. FBA gives an optimal flux distribution to achieve
a desired performance whereas

13

C-MFA quantifies the in vivo operation of a cell. The two

techniques complement each other and can be utilized to locate bottlenecks in metabolic
pathways for the synthesis of a desired product (Figure 1.3).
Finally, the current flux analysis disregards the dynamic metabolic behavior of a
biological system. This avoids the difficulties in solving large-scale kinetic models and
performing time-dependent experimental measurements. However, many biological systems
cannot maintain a metabolic (or isotopic) steady state during the entire cultivation process. The
flux modeling for dynamic metabolite concentrations or isotopic labeling requires the innovative
approaches to link kinetic model to metabolic flux analysis.

11

Figure 1.3: Metabolic network modeling and analysis. FBA profiles the "optimal" metabolism
for the desired performance (can be genome-scale); 13C-MFA measures in vivo operation of the
central metabolic network (< 100 reactions).

12

Chapter 2: Statistics-based model for prediction of chemical
biosynthesis yield from Saccharomyces cerevisiae
This chapter has been reproduced from the following publication:
Varman, A.M., Xiao, Y., Leonard, E. & Tang, Y. Statistics-based model for prediction of
chemical biosynthesis yield from Saccharomyces cerevisiae. Microbial Cell Factories 10, 45
(2011).

Abstract
Background
The robustness of Saccharomyces cerevisiae in facilitating industrial-scale production of
ethanol extends its utilization as a platform to synthesize other metabolites, both native and of
heterologous origins. Metabolic engineering strategies, typically via pathway overexpression and
deletion, continue to play a key role for optimizing the conversion efficiency of substrates into
the desired products. However, chemical production titer or yield remains difficult to predict
based on reaction stoichiometry and mass balance. We sampled a large space of data of chemical
production from S. cerevisiae, and developed a statistics-based model to calculate production
yield using input variables that represent the number of enzymatic steps in the key biosynthetic
pathway of interest, metabolic modifications, cultivation modes, nutrition and oxygen
availability.

Results
Based on the production data of about 40 chemicals produced from S. cerevisiae, metabolic
engineering methods, metabolite supplementation, and fermentation conditions described
therein, we generated mathematical models with numerical and categorical variables to predict
13

production yield. Statistically, the models showed that: 1. Chemical production from central
metabolic precursors decreased exponentially with increasing number of enzymatic steps for
biosynthesis (>30% loss of yield per enzymatic step, P-value=0); 2. Categorical variables of gene
overexpression and knockout improved product yield by 2~4 folds (P-value<0.1); 3. Addition of
notable amount of intermediate precursors or nutrients improved product yield by over five folds
(P-value<0.05); 4. Performing the cultivation in a bioreactor enhanced the yield of product by
three folds (P-value<0.05); 5. Contribution of oxygen to product yield was not statistically
significant. Yield calculations for various chemicals using the linear model were in fairly good
agreement with the experimental values. The model generally underestimated the ethanol
production as compared to other chemicals, which supported the notion that the metabolism of
Saccharomyces cerevisiae has historically evolved for robust alcohol fermentation.

Conclusions
We generated simple mathematical models for first-order approximation of chemical
production yield from S. cerevisiae. These linear models provide empirical insights to the effects
of strain engineering and cultivation conditions toward biosynthetic efficiency. These models
may not only provide guidelines for metabolic engineers to synthesize desired products, but also
be useful to compare the biosynthesis performance among different research papers.

2.1 Background
Producing small-molecule chemicals from microbial biocatalysts offers several
advantages. Unlike conventional chemical synthesis which are heavily dependent on petroleumderived substrates, microbes are able to use renewable materials to synthesize many commodity
14

chemicals and fuels

7

(Figure 2.1). Due to its scalability, microorganisms are also suitable

platforms to synthesize pharmaceutical molecules that are conventionally produced from
extracting large amounts of natural resources. Among many industrial microorganisms, the
baker’s yeast, i.e., S. cerevisiae continues to emerge as a preferred production platform
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. S.

cerevisiae is typically known for its robustness in fermenting sugars into alcohol. In the recent
past, it has also gained importance as a heterologous platform to synthesize many precursors of
commodity chemicals and pharmaceuticals 7. In general, chemical production using whole-cell
biocatalysts are achieved by genetic engineering to extend the substrate range of an existing
biosynthetic pathway or to introduce new biosynthetic pathways (either derived from other
organisms, or completely novel). Rational metabolic engineering approaches then analyze the
cellular metabolism and improve production titer by overexpressing rate-limiting enzymes or
deleting competing pathways. In general, the actual yield of chemical production is not easily
predicted due to the complexity of biological systems and dependency of cultivation conditions.
Biological complexities not only include intrinsic properties (such as enzyme kinetics and
substrate specificity), but also include enzyme compartmentalization, intracellular signaling, and
metabolite transport between eukaryotic cell organelles. Therefore, strain engineering requires
multiple rounds of trial-and-error experiments to perform the optimum combination of genetic
manipulations. In the present work, we sought to develop mathematical models that could
provide a priori estimation of chemical production yield from engineered S. cerevisiae when
given a set of parameters, namely the number of steps in the biosynthetic pathway of interest,
genetic modifications, cultivation conditions, and nutrient and oxygen availability. The
coefficients of these parameters were obtained from the regression of the yields and production
conditions reported by recent literatures. Such model predicted the empirical yields that were
15

lower than the theoretical productivities under “ideal” conditions. The model results could give
metabolic engineers guidelines for increasing desired products and for reducing futile attempts.

2.2 Model development
The model defined several important parameters that influenced the efficiency of
chemical production from microbial hosts. The first group of parameters accounted for the
number of enzymatic steps in the biosynthetic pathway of interest since it had been shown that
this parameter was often inversely correlated with microbial product yield 9. To enumerate the
number of enzymatic steps, we introduced two numerical variables in our model, i.e. PRI and
SEC. The variable PRI specified the number of enzymatic steps in primary metabolism (Figure
2.1), e.g. glycolysis that is required to convert sugar (glucose or galactose) to pyruvate. The
variable SEC specified the number of enzymatic steps in the subsequent pathway (typically
belongs to secondary metabolism), which catalyzed the conversion of central carbon
intermediate into the final product of interest. The next group of variables was to capture the
effects of genetic modification. Various genetic strategies have been used to implement
metabolic engineering 4, 34. For example, promoters with different strength influence production
level. However, for the sake of simplifying our model, variations of genetic components used in
metabolic engineering strategies were lumped into two ordinal variables, i.e. OVE, and KNO.
OVE signified the introduction of multiple copies of genes of native or heterologous origin for
the purpose of improving production level. KNO signifies the alteration of branch pathways that
might compete with the pathway of interest

5, 36

. We further sub-categorized OVE based on the

number of modified genes into OVEC1 (without “pushing” pathway flux), OVEC2 (enhancing 1~2
enzyme activities), and OVEC3 (improving a number of key enzyme functions). KNO was also
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categorized by KNOC1 and KNOC2 (i.e., without knockout or with knockout, respectively). Table
2.1 explained the specifications for each sub-category.
The yield of metabolite production is also a function of cultivation conditions and nutrient
availability. For instance, production of metabolites from a bioreactor is often higher than a
shaking flask, due to the increased efficiency of mass transfer of oxygen, substrates, and
nutrients. Moreover, culture acidification that often generates cytotoxicity and maintenance
burden to the microbial hosts can be mitigated in a bioreactor by automated pH control. Based on
these basic properties, we introduced the variable CUL to represent the general property of a
cultivation condition. We also introduced the variable OXY and NUT to capture the effects of
oxygen availability and nutrient supplementation, respectively37-39. Moreover, the variable INT
captured the effect of addition of a secondary carbon source which served as a precursor or an
intermediate metabolite of the pathway of interest.
Several assumptions were made to simplify our model development. A) Yield calculation was
based on the conversion of major carbon substrate to final product if multiple nutrient sources
were supplemented (e.g., yeast extract was not treated as the carbon source). B) We calculated
the yields based on two factors: initially added carbon substrate in the culture and final measured
product. We neglected the unused carbon substrate that remained in the end of the production. C)
To calculate enzymatic steps from the carbon source, the model only considered the key route
from the major substrate (mostly glucose) to the final products (enzyme steps for co-factors or
ATPs synthesis were neglected). D) For product synthesis promoted by the addition of an
intermediate, we had no means of differentiating the carbons derived from added precursor or
from the carbon substrate (i.e., glucose). To account for the contribution from both carbon
17

sources, the yield calculation was assumed to be an arithmetic mean of the two yields (One yield
was based on substrate, e.g., glucose, and the other yield was estimated from the intermediates).
Meanwhile, the number of primary steps or secondary steps were also assumed as an arithmetic
mean of two data sets (one variable was counted from substrate; the other variable was counted
from the intermediate).
Biochemical systems theory 34 states that reaction rates (νi) can be described by a general power
law expression of the type:

ν i =αi ∏ X j ij
g

(2.1)

j

Where Xj represents the system variables and the parameters αi , gij are the constants. Equation
(2.1) yields a linear form in logarithmic coordinates. Based on similar assumptions, our model
for yield prediction used system variables (i.e., numerical or categorical variables related to yeast
biosynthesis) to describe the relative carbon flux to the final products.
log10 Y = β0 + βPRIPRI + βSECSEC + βOVE,C2OVEC2 + βOVE,C3OVEC3 + βKNO,C2KNOC2 +
βNUT,C2NUTC2 + βINT,C2INTC2 + βCUL,C2CULC2 + βOXY,C2OXYC2

(2.2)

In Equation 2.2, log10 Y was the dependent variable which represented production yield (mol C
in product/mol C in primary substrate), given each independent variables βi 40. We defined β0 as
the intercept in Equation 2.2, which represented the combined contribution of Category 1 of all
ordinal variables. β0 was defined as:
β0 = βOVE,C1 + βKNO,C1 + βNUT,C1 + βINT,C1+ βCUL,C1 + βOXY,C1
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(2.3)

The ordinal variables (using a binary system) were assigned a value of one if and only if the
condition fitted the category in Table 2.1. Otherwise, the ordinal variables were assigned a value
of 0

41

. (2) To acquire the coefficients in Equation 2.2 and 2.3, we compiled data from ~40

publications which described the production of chemicals by S. cerevisiae under various
experimental conditions. Table 2.2 summarized the categories assigned to these experimental
conditions and the yield of product from our best judgment. Using these data, we performed
regression analysis to fit the model via the software package R
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to find the regression

coefficients and P-values. For this study, a variable was statistically significant (90%) if its Pvalue was below 0.1.

2.3 Results and discussion
We constructed simple models which linked several numerical and ordinal variables that
affected the yield of chemical production from S. cerevisiae. These ordinal variables consisted of
the number of modified genes or pathways (OVE), the number of gene knockouts in known
competitive pathways (KNO), nutrient source (NUT), intermediate (INT), cultivation mode
(CUL), and oxygen availability (OXY). We described the yield of chemical production as the
summation of these independent variables in Equation 2.2. We fitted Equation 2.2 and
determined the coefficients of the variables using linear regression analysis of ~40 compounds.
Although multiple data of production yields were often reported in each literature, the model
only considered the best yield under a denoted experimental condition. Then, all experimental
conditions were categorized by numerical and ordinal variables. The linear regression
coefficients obtained for Equation 2.2 were given in Equation 2.4, such that:
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log Y = -1.53 -0.01 PRI – 0.19 SEC + 0.007 OVEC2 + 0.52 OVEC3 + 0.31 KNOC2 + 0.73 NUTC2
+ 0.77 INTC2 + 0.51 CULC2 + 0.27 OXYC2

(2.4)

The accuracy of obtained coefficients in Equation 2.4 was evaluated based on R2 and the Pvalue. Here, we used a P-value of 0.1 as the limit below which the result was considered
significant
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. Out of the eight variables specified in our model, SEC, OVE, KNO, NUT, INT

and CUL had P-value of less than 0.1. The summary of the P-value of each variable was listed in
Table 2.3. Figure 2.2A showed a plot of the production yields obtained experimentally and those
obtained from model prediction for the corresponding conditions. The correlation of this model
to the dataset had an R2 value of 0.55, which reflected the moderate discrepancy between
reported yields and the model-predicted yields. Figure 2.2B plotted the residuals of model fitting.
The residuals appeared to scatter around zero randomly, so the linear model was proper to
describe the experimental data.
Interestingly, the number of enzymes in the primary pathway (PRI) did not significantly affect
production yield (P-value = 0.76) (Table 2.3). This suggested that rate-limiting steps to increase
chemical production flux often lay in the downstream pathway of central metabolism. The
coefficient of SEC was negative. This suggested that the length of a pathway downstream of
central metabolism negatively affected production yield. Specifically, addition of a new
enzymatic step in a secondary metabolic pathway reduced product yield by 36% (for numerical
variable SEC: 10βSEC =10-0.19 =64%). A good demonstration of the effect of pathway length on
product yield was found in the case of naringenin production

44

. With the following inputs of

variables PRI = 10 (Galactose to PEP), SEC = 14 (i.e., 10 steps from PEP to phenylalanine; 4
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steps from phenylalanine to flavanone), KNO = INT = CUL = OXY = category 1, NUT =
Category 2; OVE = Category 3; the model calculated:
Yield= 10-1.53- (0.01×10) + (-0.19×14) + 0.52+0.73= 0.0009 (The reported experimental production yield was
0.00058). In most cases, our model-predicted yields were within the range of one order of
magnitude compared to the experimental values.
Since the number of steps in central metabolism (PRI) did not significantly affect production
yield, we computed another set of regression coefficients for Equation 2 without the variable
PRI, to yield a simplified form Equation 2.5.
log Y = -1.60 – 0.19 SEC + 0.0003 OVEC2 + 0.50 OVEC3 + 0.31 KNOC2 + 0.73 NUTC2 + 0.82
INTC2 + 0.51 CULC2 + 0.28 OXYC2

(2.5)

As shown in Table 2.3, regression using Equation 2 with the exclusion of the variable PRI did
not change the R2 value. This result indicated that the number of enzymatic steps in primary
metabolism did not significantly affect product yield. Presumably, fluxes in central metabolic
pathways were typically high and robust
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, when compared to those downstream secondary

pathways. It has been demonstrated recently that production of chemicals was significantly
improved, only when the capacity of a downstream pathway was increased 46.
Metabolic engineering typically involves pathway modification to shift metabolic fluxes into a
desired product or to permit the use of an alternative carbon source

47

. We defined the variable

OVE, and KNO in Equation 2.2 to capture the effect of pathway overexpression, and deletion,
respectively. The regression of experimental data using Equation 2.2 showed that the coefficients
of OVEC2 and OVEC3 had positive values (Table 2.3). The model successfully captured the
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contribution of both pathway overexpression and gene deletions to increase product yield in S.
cerevisiae. The high P-value of OVEC2 (0.98) indicated that statistically, the overexpression of a
small number of genes (1-2) was uncertain to improve production yield. However, the coefficient
of OVEC3 (=0.52; P-value=0.07) indicated the effectiveness of multiple gene modification to
resolve the bottleneck steps. This observation is consistent to the fact that metabolic fluxes
generally do not sensitively respond to changes of single enzyme activity, but are controlled by
all key enzymes along the biosynthesis pathway. On the other hand, the regression coefficients of
KNOC2 had positive value (=0.31, P-value = 0.08), and thus the removal of competitive
pathways could be effective to increase production yield.
It is a general knowledge that bioprocess conditions affect cellular viability and product yield.
Our model suggested fermentation using a well-controlled bioreactor improved production yield
by 3.2 times (CULC2:10βCUL,C2 = 100.51). The model further suggested that fermentation under
anaerobic or microaerobic condition could enhance yield compared to aerobic fermentation.
However, such enhancement was not statistically significant (P-value = 0.32). This observation
could be explained by the fact that S. cerevisiae produced fermentative products (ethanol and
glycerol) (Crabtree effect) 48, 49 under aerobic and glucose-sufficient medium. Therefore, aerobic
metabolism in S. cerevisiae could operate similarly to metabolism under oxygen-limited
condition. The coefficient for the variable INT was 0.77, which represented that the
supplementation of a precursor metabolite translated to an approximately six fold increase of the
product yield (P-value = 0.02). Similarly, the addition of nutrients (such as yeast extract) also
significantly increased production yield (the coefficient of NUTC2 was 0.73). The contributions
of INT and NUT to product formation indicated that intermediates/nutrients provided building
blocks or energy sources that reduced the rate-limiting steps in biosynthetic pathways.
22

We used Equation 2.2 to compute the production yield of chemicals according to the
specifications listed in Table 2.2. We observed that, for ethanol production, the experimental
values were generally higher than the empirical model predictions. In reality, the reported
maximum ethanol yield could reach 0.5 mol C-ethanol / mol C-glucose
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, which could be

several folds higher than model predictions. To mitigate this discrepancy, we re-categorized the
ethanol synthesis pathway as the primary pathway to generate Equation 2.6.
log Y = -1.73 +0.003 PRI – 0.19 SEC + 0.05 OVEC2 + 0.56 OVEC3 + 0.37 KNOC2 + 0.71 NUTC2
+ 0.86 INTC2 + 0.51 CULC2 + 0.12 OXYC2

(2.6)

Regression of the data using Equation 2.6 improved the R2 value from 0.55 to 0.58,
demonstrating that ethanol could be better assumed as a central metabolite for S. cerevisiae.
Using Equation 2.6, we predicted ethanol production based on a recent reference
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by

specifying PRI = 11, SEC = 1 (cellulose degradation step), OVE = C3, KNO = C1; NUT = C2,
INT = C1, CUL = C1, and OXY = C2. The ethanol production yield calculated by Equation 2.6
was 0.31. This value was in good agreement with the reported values of ~0.4 51.

2.4 Model applications and limitations
The main application of the model is to predict the biosynthesis yield from S. cerevisiae.
The model were validated by “unseen data” (Figure 2.2C) from some randomly selected new
publications (2010~2011). The model predicted the yields based on the reported experimental
conditions described by these papers

52-56

. Most yield data were close to model predictions. The

predictive power of the model was consistent with the model quality described in Table 2.3.
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Furthermore, the model can reveal the metabolic features of S. cerevisiae. For example, the
modified model Equation 2.6 showed that it was better to treat ethanol pathway as the primary
routes in cell metabolism, because of the strong ability for ethanol fermentation by yeast,
possibly due to long-term process for selecting yeast as alcohol producer through human history.
The model can also be useful for comparing the productivity among other yeast species (Figure
2.3). For example, riboflavin producer, Candida famata, exhibits a high riboflavin productivity
(2~3 order of magnitude higher than model prediction) 57. Pichia pastoris, a common species for
protein expression, shows high S-adenosyl-L-methionine productivity if a large amount of the
intermediate methionine was repeatedly added in the medium 58. Besides, Pichia stipitis also has
high yields of L-lactic acid and ethanol from glucose and xylose 59. Figure 2.3 demonstrated that
some yeast species were able to explore their native pathways for biosynthesis of certain
products with extraordinary efficiency (better than S. cerevisiae), therefore, these yeast species
may be alternative hosts for certain biotechnology applications.
The accuracy of the model predictions for some products could be poor due to several limitations
during model development. First, the category was a rough estimation of experimental conditions
especially for variables related to gene modifications (OVE and KNO), and the yields could be
very different even in the same category. Second, some products, despite large synthesis rates,
were either not very stable or difficult to accumulate in a large quantity due to consumptions by
downstream pathways or product degradations (e.g., Glycerol 3-phosphate 60). Their yields could
be significantly lower than model predictions even though the actual flux to the product was
high. Third, the coefficient βSEC from model regression could not account for the big variances of
biosynthesis efficiency or potentially feedback inhibitions in secondary pathways. For example,
butanol synthesis is significantly improved via non-fermentative amino acid pathways compared
24

to traditional acetyl-CoA routes

61

, because amino acid synthesis pathways in microorganisms

are more effective than other heterogeneous pathways. Fourth, because of limited information
from the references, the yield calculation could not precisely include the CO2 fixation (e.g.,
overexpression of the native carboxylase pathway: pyruvate + CO2  oxaloacetate)

62

or the

nutrients utilization in the rich medium. Fifth, the model neglected enzyme steps related to
energy metabolism (such as ATP and NADPH synthesis), while cofactor imbalance can also
affect the product yields.

2.5 Comparison to the previously published E. coli model 63
Recently, we have constructed the E.coli model using same modeling approach.
Compared to the E.coli model, S. cerevisiae shows several differences: 1. Oxygen conditions
made a more significant impact on biosynthesis yield in E.coli than that in S. cerevisiae; 2. The
genetic modification in E.coli had higher uncertainty for metabolic outcomes; 3. For metabolic
pathways from precursors to final products, loss of yield per biosynthesis step (~30%) in S.
cerevisiae is higher than that in E.coli (10~20%). Interestingly, E. coli model states that primary
metabolism influences product yield (a relatively small P-value of 0.06) which indicates the
balance of precursor production from central metabolism is also an important consideration for
metabolic engineering of E.coli. For example, it has been demonstrated that lycopene production
with E. coli was enhanced by redirecting the carbon flux from pyruvate to G3P

64

, but feeding

other central metabolite precursors (such as pyruvate) could not improve lycopene production.
On the other hand, the S. cerevisiae model indicates that it is less likely that the number of steps
in central metabolism play a bottleneck role in the production of metabolites derived from it,
while the bottlenecks are more likely in the secondary pathways (from central precursors to the
25

final product). Therefore, the metabolic strategies should focus on the secondary pathways to
have a better chance for increasing final yield. Although modification of central metabolism may
affect microbial physiologies, a few studies indicate the robustness of the central metabolism in
S. cerevisiae because of its importance to cell vitality. For example, S. cerevisiae may maintain
central metabolic fluxes via gene duplication and alternative pathways under different
environmental and physiological conditions 45, 65. Therefore, the inflexibility of central pathways
in S. cerevisiae is likely to render metabolic engineering strategies ineffective when targeting
enzymes in central metabolism. In general, the unique metabolic features of yeast and bacteria
can be of important consideration when choosing a production host.

2.6 Conclusions
Although S. cerevisiae has been widely used as a robust industrial organism for metabolic
engineering applications, many metabolic features of this organism for biosynthesis under
various conditions remain unknown. In this study, the statistic model for yeast biosynthesis
permits a priori calculation of the final product yield achievable by current biotechnology.
Unlike other in silico models based on mass balance or thermodynamics (such as FBA model) 66,
67

, our model is based on a statistical analysis of published data using numerical and ordinal

variables (categorized experimental conditions). The model has three applications. 1. The yield
prediction takes into account the genetic design of the microbial host system and the
“suboptimal” conditions under which the fermentation process occurs.

2. The model may

identify effective metabolic strategies and at the same time, quantitatively provide the degree of
uncertainty (i.e., possibility for failure). For example, statistical analysis shows that, for S.
cerevisiae, metabolic bottlenecks may be more likely to be in the secondary metabolic pathways
26

rather than primary pathways, and thus it can narrow down the genetic targets and avoid futile
work. 3. This model may be used to qualitatively benchmark yields of different engineered
production platforms.
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Figure 2.1: Metabolic pathway for the biosynthesis of major products. The blue box represents
central metabolism and the yellow box represents secondary metabolism. Solid arrows signify
single step reaction and dotted arrows signify multiple steps. Abbreviations: ACoA – AcetylCoA; DAP – Dihydroxyacetone-Phosphate; DAHP – 3-Deoxy-D-Arabino-Heptulosonate-7Phosphate; DHA – Dihydroxyacetone; F6P - Fructose-6-Phosphate; FBP – Fructose 1,6bisphosphate; G6P – Glucose-6-Phosphate; GADP – Glyceraldehyde-3-Phosphate; Oxa –
Oxaloacetate; Oxo – 2-Oxoglutarate; PEP – Phosphoenolpyruvate; PHB – Poly[(R)-3hydroxybutyrate]; pHCA – p-Hydroxycinnamic acid; R5P – Ribose-5-Phosphate; Ru5P –
Ribulose-5-Phosphate; Suc – Succinate; X5P – Xylulose-5- Phosphate.
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Figure 2.2 A
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Figure 2.2 B
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Figure 2.2 C

Figure 2.2: Model results. A) Plot of the actual logarithmic yields against the logarithmic yields
generated by the regression model. The line drawn as diagonal to the plot is one-to-one and
passes through the origin. The data points have an R2 value of 0.55. B) Plot of residuals against
fitted values. C) Model validation using newly published data (2010~2011) 1 - β-amyrin 52; 2 ascorbic acid 53; 3 – monoterpene 54; 4 – vanillin 55; 5 - succinic acid 56.
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Figure 2.3: S. cerevisiae model prediction of biosynthesis yields for other industrial yeast
species 57-59, 68-70. Ethanol:
or
. L-lactic acid: .
Lycopene: . Riboflavin: + or X .
S-adenosyl-L-methionine: ─ .
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Table 2.1: Ordinal variables used in the linear regression model
Ordinal variables
OVE: number of
modified genes or
pathways
KNO: number of gene
knockouts in known
competitive pathways
NUT: nutrient source

INT: Intermediate
CUL: cultivation
mode

OXY: oxygen
conditions

Category 1
(subscript C1)
No modified genes or
pathways were
present.

Category 2
(subscript C2)
One or two modified
genes or pathways
were present.

No gene knockouts
were performed.

Gene knockouts were
performed.

Fermentation
occurred in defined
medium (only
including trace
amounts of amino
acids or vitamins)
Intermediate was not
added
Fermentation
occurred in a shaking
flask.

Fermentation
occurred in a very
rich medium.

Fermentation
occurred in aerobic
conditions.

Category 3
(subscript C3)
More than two
modified genes or
pathways were
present.

Intermediate was
added
Fermentation
occurred in a batch,
fed-batch, or
continuous feed
bioreactor.
Fermentation
occurred under
oxygen-limited
conditions (anaerobic
or micro-aerobic).

Note: the input of ordinal variables was specified using a binary system, 1 and 0. When a
category (e.g., overexpression Category 2) was applied, the value 1 was assigned to OVEC2.
Otherwise, the value 0 was assigned.
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Table 2.2: Dataset used for linear regression

Reference
71
71
71
71
71
71
71
72
73
73
74
74
75
76
77
78
78
78
78
78
78
79
79
79

Yield

Primary
Step

Second
Step

OVE_C2

OVE_C3

KNO_C2

NUT_C2

INT_C2

CUL_C2

OXY_C2

(E,E,E)-Geranylgeraniol

0.00025

10

10

1

0

0

1

0

0

0

(E,E,E)-Geranylgeraniol

0.014

10

10

0

1

0

1

0

0

0

(E,E,E)-Geranylgeraniol

0.047

10

10

0

1

0

1

0

0

0

(E,E,E)-Geranylgeraniol

0.018

10

10

0

1

0

1

0

0

0

(E,E,E)-Geranylgeraniol

0.031

10

10

0

1

0

1

0

0

0

(E,E,E)-Geranylgeraniol

0.058

10

10

0

1

0

1

0

0

0

(E,E,E)-Geranylgeraniol

0.14

10

10

0

1

0

1

0

1

0

1,2-Propanediol

0.014

4

3

1

0

0

1

0

0

0

1,2-Propanediol

0.010

4

3

1

0

0

1

0

1

0

1,2-Propanediol

0.026

4

3

1

0

0

1

0

1

0

5-epi-aristolochene

0.010

10

9

1

0

1

1

0

0

0

5-epi-aristolochene

0.0090

10

9

1

0

1

1

0

0

0

Acetate

0.13

9

2

0

0

1

0

0

1

0

Acetate

0.015

9

2

0

0

1

0

0

1

0

Product

Acetate

0.26

9

2

0

1

0

0

0

0

1

Amorphadiene

0.00049

12

9

1

0

0

0

0

0

0

Amorphadiene

0.0020

12

9

1

0

0

0

0

0

0

Amorphadiene

0.0040

12

9

1

0

1

0

0

0

0

Amorphadiene

0.011

12

9

1

0

1

0

0

0

0

Amorphadiene

0.016

12

9

0

1

1

0

0

0

0

Amorphadiene

0.016

12

9

0

1

1

0

0

0

0

Amorphadiene

0.0080

12

9

1

0

1

0

0

0

0

Amorphadiene

0.0090

12

9

0

1

1

0

0

0

0

Amorphadiene

0.011

12

9

0

1

1

0

0

0

0
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79
78
78
80
80
80
81
81
82
83
83
83
83
50
50
84
84
84
85
85
85
85
85
76
76
86
77
77
77
87

Amorphadiene

0.013

12

9

0

1

1

0

0

0

0

Artemisinic acid

0.0030

12

10

0

1

1

0

0

0

0

Artemisinic acid

0.011

12

10

0

1

1

0

0

1

0

Cyanophycin

0.12

10(0)

2(1)

1

0

1

1

1

0

0

Cyanophycin

0.10

10(0)

2(1)

1

0

1

1

1

0

0

Cyanophycin

0.15

10(0)

2(1)

1

0

1

1

1

0

0

Dihydroxyacetone

0.0040

4

3

1

0

0

0

0

0

0

Dihydroxyacetone

0.034

4

3

1

0

1

0

0

0

0

D-Lactic acid

0.61

9

1

1

0

1

1

0

0

1

Dolichol

0.00010

10

11

0

0

0

1

0

0

0

Dolichol

0.00018

10

11

1

0

0

0

0

0

0

Ergosterol

0.00015

10

21

0

0

0

1

0

0

0

Ergosterol

0.00020

10

21

1

0

0

0

0

0

0

Ethanol

0.55

9

2

1

0

0

0

0

1

1

Ethanol

0.47

8

2

0

1

0

0

0

1

1

Ethanol

0.080

8

2

0

1

0

0

0

1

0

Ethanol

0.12

8

2

0

1

0

0

0

1

1

Ethanol

0.15

8

2

0

1

0

0

0

1

1

Ethanol

0.53

9

2

1

0

0

1

0

0

0

Ethanol

0.20

9

2

1

0

0

1

0

0

0

Ethanol

0.47

9

2

1

0

0

1

0

0

0

Ethanol

0.42

9

2

0

0

0

1

0

0

0

Ethanol

0.36

9

2

0

0

0

1

0

0

0

Ethanol

0.44

9

2

0

0

1

0

0

1

0

Ethanol

0.32

8

2

0

0

1

0

0

1

1

Ethanol

0.52

9

2

1

0

0

0

0

0

0

Ethanol

0.55

9

2

0

1

0

0

0

0

1

Ethanol

0.39

9

2

0

1

0

0

0

0

1

Ethanol
Ethylene*

0.51

9

2

0

1

1

0

0

0

1

0.00069

13

10

1

0

0

0

0

1

0

35

74
88
88
89
89
90
90
90
91
91
75
75
75
92
92
76
76
93
93
60
94
94
94
94
95
96
97
97
90
90

Farnesol

0.036

10

9

0

0

1

1

0

0

0

Flavanones

0.030

10(0)

14(3)

0

1

0

0

1

0

0

Flavanones

0.053

10(0)

14(3)

0

1

0

0

1

0

0

Formate

0.00024

6

7

0

0

1

0

0

0

0

Formate

0.00030

6

7

0

0

1

0

0

0

0

Geraniol

0.00011

10

8

1

0

0

0

0

0

0

Geraniol

0.00019

10

8

1

0

1

0

0

0

0

Geraniol

0.00019

10

8

1

0

1

0

0

0

0

Glycerol

0.12

4

2

1

0

0

0

0

1

0

Glycerol

0.12

4

2

1

0

0

0

0

1

0

Glycerol

0.41

4

2

1

0

1

0

0

1

0

Glycerol

0.45

4

2

1

0

1

0

0

1

0

Glycerol

0.45

4

2

1

0

1

0

0

0

0

Glycerol

0.49

4

2

0

0

1

1

0

1

0

Glycerol

0.41

4

2

0

0

1

1

0

1

0

Glycerol

0.050

4

2

0

0

1

0

0

1

0

Glycerol

0.037

2

4

0

0

1

0

0

1

1

Glycerol

0.45

4

2

0

0

1

0

0

1

0

Glycerol

0.54

4

2

1

0

1

0

0

1

0

0.0010

4

1

1

0

1

0

0

0

1

Glycerol 3-phosphate
Hydrocortisone

0.0020

10(0)

19(2)

1

0

0

1

1

0

0

Hydrocortisone

0.0020

10(0)

19(2)

1

0

1

1

1

0

0

Hydrocortisone

0.021

10(0)

19(2)

1

0

1

1

1

0

0

Hydrocortisone

0.026

10(0)

19(2)

1

0

1

1

1

0

0

Lactate

0.44

9

1

1

0

0

1

0

1

0

Lactate

0.21

9

1

1

0

0

0

0

1

0

L-Ascorbic acid

0.14

2(0)

8(2)

1

0

0

0

1

0

0

L-Ascorbic acid

0.066

2(0)

8(2)

1

0

0

0

1

0

0

Linalool

8.8 x 10

-5

10

8

1

0

0

0

0

0

0

Linalool

2.3 x 10-5

10

8

1

0

1

0

0

0

0
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98
62
79
79
99
99
44
23
99
100
100
44
101
101
101
101
101
101
101
101
74
74
102
76
103
104
104
104
104
71

L-Lactic Acid

0.65

9

1

1

0

1

1

0

0

0

Malate

0.28

11

0

0

1

0

0

0

0

0

Mevalonate

0.022

12

3

0

1

1

0

0

0

0

Mevalonate

0.022

12

3

0

1

1

0

0

0

0

Naringenin

0.0070

8(0)

15(3)

0

1

0

0

1

0

0

Naringenin

0.0020

8(0)

15(5)

0

1

0

0

1

0

0

Naringenin

0.00058

10

14

0

1

0

1

0

0

0

n-Butanol

0.00020

12

6

0

1

0

0

0

0

1

p-Coumaric Acid

0.033

8(0)

12(2)

0

1

0

0

1

0

0

p-Hydroxycinnamic acid

0.00020

8

12

1

0

0

0

0

0

0

p-Hydroxycinnamic acid

0.20

8(0)

12(2)

1

0

0

0

1

0

0

Pinocembrin

6.6x10

-5

10

14

0

1

0

1

0

0

0

Poly[(R)-3-hydroxybutyrate]

0.00056

10

3

1

0

0

0

0

0

0

Poly[(R)-3-hydroxybutyrate]

0.003

10

3

1

0

0

0

0

0

0

Poly[(R)-3-hydroxybutyrate]

0.012

10

3

0

1

0

0

0

0

0

Poly[(R)-3-hydroxybutyrate]

0.00047

10

3

1

0

0

0

0

1

0

Poly[(R)-3-hydroxybutyrate]

0.0090

10

3

1

0

0

0

0

1

0

Poly[(R)-3-hydroxybutyrate]

0.018

10

3

0

1

0

0

0

1

0

Poly[(R)-3-hydroxybutyrate]

0.0010

10

3

0

1

0

0

0

1

1

Poly[(R)-3-hydroxybutyrate]

0.017

10

3

0

1

0

1

0

0

0

Premnaspirodiene

0.011

10

9

1

0

1

1

0

0

0

Premnaspirodiene

0.0090

10

9

1

0

1

1

0

0

0

Pyruvate

0.55

9

0

0

0

1

0

0

1

0

Pyruvate

0.0050

9

0

0

0

1

0

0

1

0

Reticuline

0.051

8(0)

16(3)

0

1

0

0

1

0

0

Ribitol

0.0020

5

2

0

0

1

0

0

0

0

Ribitol

0.027

5

2

1

0

1

0

0

0

0

Ribitol

0.017

5

2

1

0

1

0

0

0

0

Ribitol

0.021

5

2

1

0

1

0

0

0

0

Squalene

0.042

10

9

1

0

0

1

0

0

0
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105
106
104
104
104
77
77

Taxadiene

7.7x10-5

12

8

0

1

0

1

0

0

0

Vanillin

0.0030

3

6

0

1

1

1

0

0

0

Xylitol

0.0070

5

2

1

0

1

0

0

0

0

Xylitol

0.014

5

2

1

0

1

0

0

0

0

Xylitol

0.014

5

2

1

0

1

0

0

0

0

Xylitol

0.27

5

2

0

1

0

0

0

0

1

Xylitol

0.29

5

2

0

1

1

0

0

0

1

10

14

1

0

0

0

0

0

0

107

β-carotene

107
107

4.5x10

-7

β-carotene

2.9x10

-6

10

14

0

1

0

0

0

0

0

β-carotene

0.00011

10

14

0

1

0

0

0

0

0

107

β-carotene

0.00036

10

14

0

1

0

0

0

0

0

107

β-carotene

0.0010

10

14

0

1

0

0

0

0

0

Note: Some papers show that product biosynthesis can be enhanced by supplementing additional precursors. In the parenthesis, we
have listed the number of enzyme steps from the added intermediates to final products.
* Steps for ethylene were counted based on the arginine route.
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Table 2.3: Regression coefficients and P-values for S. Cerevisiae model

Variable
Intercept
Primary
step
Secondary
step
OVE C2
OVE C3
KNO C2
NUT C2
INT C2
CUL C2
OXY C2
Multiple R2

Model 1
With primary steps
Coefficient P-value
Std. Error

Model 2
Without primary steps
Coefficient
P-value Std. Error

Model 3
Ethanol as a primary metabolite
Coefficient
P-value
Std. Error

-1.53

0

0.42

-1.60

0

0.34

-1.73

0

-0.01

0.76

0.04

-

-

-

0.003

0.93

-0.19

0

0.02

-0.19

0

0.02

-0.19

0

0.02

0.007
0.52
0.31
0.73
0.77
0.51
0.27

0.98
0.07
0.08
0
0.02
0.02
0.32

0.26
0.29
0.18
0.18
0.31
0.22
0.27

0.0003
0.50
0.31
0.73
0.82
0.51
0.28

0.99
0.079
0.078
0
0.001
0.02
0.31

0.25
0.28
0.18
0.18
0.25
0.21
0.27

0.05
0.56
0.37
0.71
0.86
0.51
0.12

0.84
0.05
0.03
0
0.004
0.02
0.65

0.24
0.28
0.17
0.17
0.29
0.21
0.27

0.55

0.55
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0.58

0.41
0.03

1

Chapter 3: The use of 13C-based analysis to elucidate the

2

intrinsic biosynthesis yields

3
4
5

This chapter has been submitted for peer-review and the author would like to thank all the coauthors for their contributions.

6

Abstract

7

Microbial platforms have widely been used for the synthesis of diverse value-added

8

chemicals. Rational metabolic engineering and optimal fermentations can improve microbial cell

9

factory’s yields from renewable feedstock. However, very few studies have rigorously

10

investigated the intrinsic product yields from engineered microbial platforms under complex

11

cultivation conditions. In this paper, we discuss the use of

12

assessment of product yields in four different cases. First, in the rich medium fermentation,

13

undefined nutrients (such as yeast extract) may also contribute to the synthesis of final product.

14

Second, product synthesis may be dependent on co-metabolism of multiple-feedstock. Third,

15

multiple pathways may be employed by microbes for product synthesis. Fourth, the loss of

16

ATP/NADH due to cell maintenance and low P/O ratio (Phosphate/Oxygen Ratio) reduces

17

product yields, while

18

suboptimal energy metabolism on microbial productivity. Since product yield is a major

19

determining factor in biotechnology commercialization, we foresee that

20

experiments, even without performing extensive 13C-flux calculations, can play valuable roles in

21

the development of microbial cell factories.

13

13

C-based metabolite analysis for

C-metabolic flux analysis (13C-MFA) can assess the influence of

13

C-isotopic labeling

22
23

Keywords: cell maintenance, co-metabolism, metabolic flux analysis, P/O ratio, yeast extract
40

1
2
3

3.1 Introduction
Recent advances in metabolic engineering has enabled us to engineer microbial cell factories
108

4

for the efficient synthesis of diverse products, including bulk chemicals, drugs and fuels

5

example, advanced biofuels produced by engineered microorganisms with properties similar to

6

that of petroleum-based fuels, are being reported extensively 25, 109-112. The emergence of systems

7

biology and synthetic biology has greatly increased the potential of microbial cell factories

8

towards the production of value-added chemicals

9

titer, and rate so that microbial cell factories can be moved from lab scale to industrial
114, 115

113

. For

. This has also improved product’s yield,

10

fermentations

11

production of the bulk and commodity chemicals

12

difficult if fermentations use either rich-mediums or multiple feedstock (Figure 3.1). Moreover,

13

new pathways/enzymes are often employed to improve microbial productivity and their relative

14

contribution to product yield remains unknown 24, 109, 117, 118. Thereby, a proper technique for the

15

quantification of intrinsic yields from the engineered pathways is needed if multiple biosynthesis

16

routes are used by microbial hosts.

17

. The product yield is a key indicator in achieving an economical bio116

. But, estimation of product yield may be

13

C-tracing experiments can rigorously determine the in vivo carbon fluxes from specific
13

18

substrates to final products. Feeding microbial cultures with

19

unique isotopic patterns amongst the cell metabolites (isotopic fingerprints)

20

provide functional characterization of metabolic pathways 120. Integration of this isotopomer data

21

with metabolic modeling (i.e.,

22

metabolic fluxes not only reveals metabolic responses to product synthesis and growth

23

conditions

121, 122

13

C-labeled substrates results in
119

, which can

C-MFA) can be used to predict cellular metabolic fluxes. The

, but can also reveal the rigid metabolic nodes for rational pathway engineering
41

1

123

2

field of biotechnology

3

additional utility of simple

4

product yields from microbial cell factories.

5
6
7
8
9

Figure 3.1: Schematic description of microbial metabolism. Many microbes have the ability to
co-metabolize diverse feedstock. Dark circles indicate labelled carbon. The enrichment of
labeling in the product acts as an indicator for the relative uptake flux of sugars.

10

. Therefore,

13

C-based analysis (i.e., pathway tracing and
124-127

13

C-MFA) are widely used in the

. Besides these common applications, this paper demonstrates the

13

C-experiments or the more complicated

13

C-MFA in determining

3.2 Product yield using rich medium

11
12

Engineered microbes may have many metabolic burdens that can inhibit both biomass

13

growth and product synthesis. To promote their productivity, rich media are commonly used in

14

fermentations as they provide diverse nutrients for cell growth and stabilize the production

15

performance of the microbe

16

substrates (e.g., sugars) and large amounts of nutrients (such as yeast extract). Multiple studies

114, 115

. Thereby, rich mediums include both primary carbon

42

1

have revealed that supplementing culture medium with yeast extract or terrific broth to

2

engineered microbes significantly improves their final biosynthesis yields

3

supplements can provide undefined building blocks for both biomass and product synthesis, it is

4

difficult to precisely calculate the actual product yield from the rich-medium fermentation. To

5

overcome this problem,

6

nutrients to product biosynthesis.

7

63, 128

. Since nutrient

13

C-analysis can be employed to gain insights into the contributions of

For example, two E. coli strains engineered for isobutanol production (i.e., a low
129

8

performance strain with an Ehrlich pathway

9

overexpression of both the keto-acid pathway and the Ehrlich pathway 130) display an increase in

10

isobutanol titer with the inclusion of yeast extract in their culture medium. Using fully labeled

11

glucose and non-labeled yeast extract as carbon sources, 13C-experiments revealed that the low-

12

performance strain derived ~50% of isobutanol carbons from yeast extract (Figure 3.2), while the

13

JCL260 strain synthesized isobutanol solely from 13C-glucose and used yeast extract mainly for

14

biomass growth

15

acid pathway can resolve the isobutanol synthesis bottleneck and effectively pull the carbon from

16

glucose to product. In another work, an E.coli strain was engineered for conversion of acetate

17

into free fatty acids via the overexpression of both acetyl-coA synthetase and the fatty acid

18

pathways. In the acetate-based fermentation, yeast extract significantly promoted fatty acid

19

productivity, resulting in 1 g/L fatty acids from ~10g/L acetate

20

with fully labeled acetate and yeast extract has shown that ~63% carbons in the free fatty acids

21

were synthesized from

22

primary substrate in a rich medium could be correctly estimated based on isotopomer analysis.

129

. This observation from

and a high performance JCL260 strain with

13

C-analysis indicates that overexpression of keto-

131 13

.

C-analysis of the culture

13

C-acetate (Figure 3.2). Thereby, the actual microbial yield from a

43

1
2
3
4
5
6
7
8
9
10

Figure 3.2: (A) Biosynthesis yield analyzed by feeding cells with 13C-substrates (such as fully
labeled glucose and acetate). (B) Relative product yields from a primary substrate (a –
Isobutanol from glucose in a low performance strain; ab – valine from glucose in a low
performance strain; b – Isobutanol from glucose in JCL260; bb – valine from glucose in JCL260)
129
; c – Free fatty acids from acetate in an E.coli strain 131; d - biomass from glucose in wild type
Synechocystis 6803 132; e - D-lactate from acetate in engineered Synechocystis 6803 133. Relative
yield is calculated based on 13C concentrations in the final product. Abbreviations: GAP,
Glyceraldehyde -3- phosphate; PYR, pyruvate; KIV, ketoisovalerate.

11

3.3 Product yield during co-metabolism of multiple carbon substrates

12
13

Algal species are able to utilize both CO2 and organic carbon substrates. Such

14

mixotrophic metabolism can alleviate the dependence of algal hosts on light and CO2 limitations,

15

and thus enable them to achieve high biomass growth rate and product titer

16

analysis has been used to track their photomixotrophic metabolisms in different scenarios. For

17

example, Synechocystis sp. PCC 6803 (blue-green algae) is a model a cyanobacterium which can

18

be engineered to produce diverse products and has capability to perform photomixotrophic
44

134 13

.

C-metabolite

1

metabolism 135. 13C-MFA has shown that CO2 contributes to 25% of Synechocystis biomass yield

2

during its mixotrophic growth with

3

has also been used to track the synthesis of D-lactate in an engineered Synechocystis 6803 133. In

4

that study, the lactate production was found to be increased substantially during the co-

5

metabolism of both CO2 and acetate. Experiments with fully labeled acetate and

6

discovered that nearly all of lactate molecules were non-labeled and that only the acetyl-CoA-

7

derived proteinogenic amino acids (leucine, glutamate and glutamine) were

8

result suggested that acetate was involved only in biomass growth, while the yield of D-lactate

9

was completely derived from CO2. 13C-results also further indicated that acetate may inhibit the

10

pyruvate decarboxylation reaction and thus redirect flux to lactate. The above study shows the

11

value of 13C-analysis to improve our understanding of pathway regulations for product synthesis.

12

Since many microbial platforms (including both algal species and heterotrophs) may co-

13

metabolize multiple carbon substrates simultaneously, isotopomer feeding can reveal the

14

contributions of each substrate to key metabolite pools, and thus predict the potential bottlenecks

15

in biomass or product formations.

16
17

3.4 Accurate laboratory analysis of product concentrations

13

C-glucose and

12

CO2 132. Besides,

13

C-metabolite analysis

13

12

CO2

C-labeled. This

18

Direct measurement of product concentrations in the culture can obtain deceptive results.

19

There are a few cases that cause product measurement errors. First, loss of volatile products

20

(such as alcohols) during fermentation may reduce product titers. Second, product may be

21

degraded or consumed by contaminated microbes during fermentation process. For example,

22

photochemical degradation of isobutanol synthesis from cyanobacteria was reported

23

aerobic fermentation in shake flasks may have significant water vaporization during long-term
45

136

. Third,

1

incubation because the cultivation volume is relatively small (<50mL working volume) and thus

2

the product concentration may be condensed (e.g., 10~20% water loss was normally observed

3

after three-day shaking flask cultivations at 37 oC). In all these circumstances, the final product

4

yield could be very different from the intrinsic microbial product yield. To obtain the true

5

productivity, in situ product recovery is a common method to reduce product loss. For example,

6

volatile alcohol products can be trapped in organic solvents during microbial fermentation (e.g.,

7

gas striping) 130, 136, 137. Alternatively, kinetic model can be used to obtain intrinsic product yields

8

via parameter estimation based on complete time-course fermentation data and statistical

9

analysis (to avoid local solutions) 129. Thirdly, 13C-experiments can also resolve artifacts during

10

measurement of intrinsic product yields. By addition of small amount of

13

11

culture as an internal standard, we can directly measure the change of

13

12

fermentation (Figure 3.3). Then, 13C-data from time points can be used to correct the artifact of

13

*
yield coefficients: dC = − k C * , where C* represents the 13C concentration of the product and
1

C-product in the

C-product during

dt

C*
Ct1

14

k1 is assumed the first order constant for product loss. Thereby, k1 =
− ln( t*2 ) / (t2 − t1 ) . By

15

analyzing the change in

16

calculated. The product loss term can be added to the normally measured product curves for

17

correction of intrinsic product curves.

13

C concentration at two different time points (t1 and t2), k1 can be

46

1
2
3
4
5

Figure 3.3: Schematic showing the dynamics of product concentration. Ca is the actual
concentration and Cm is the measured product concentration. C* indicates the concentration of
the 13C product added as an internal standard.

6
7

3.5 Assessment of maximum product yield

8

Theoretical product yield is generally calculated based on the stoichiometry of product

9

synthesis from a carbon substrate (without accounting both biomass growth and waste secretion).

10

However, microbial energy metabolism may also be affecting product yield which is seldom

11

accounted. The synthesis of high-energy chemicals often requires large amounts of ATPs, while

12

cell maintenance (used for regeneration of degraded macromolecules, futile cycles, and ATP

13

leaks) also competes for the same ATPs

14

source for ATP generation (theoretical P/O ratio: 1 NADH  3 ATPs) 139. However, respiration

15

efficiency in engineered strains could be poor (e.g., the P/O ratio = 1.3 during riboflavin

16

fermentation

17

compensate for the ATP demand. To illustrate the effect of cell maintenance on product yield 142,

18

a flux balance model was built to show free fatty acid production as a function of ATP

140

) due to metabolic stresses

138

. Oxidative phosphorylation of NADH is a major

141

. Thereby, a cell may consume extra substrates to

47

1

maintenance and P/O ratios (Figure 3.4) 143. This model employs eight reactions (Table 3.1) and

2

the fluxes were resolved by the function below:

3

[ max v(2)
],
such that=
A ⋅ v b and lb ≤ v ≤ ub

4

where the objective function is to maximize v(2) (i.e., the relative flux of fatty acid). A is the

5

reaction stoichiometry. lb and ub are upper and lower bound for each reaction flux, v(i). Fig.

6

3.4a shows the relationship between maximum yield, P/O ratio and ATP maintenance without

7

biomass growth (v(8)=0). A Higher P/O ratio makes the microbial system less sensitive to the

8

increased demand for ATP. When the ATP maintenance is low and the P/O ratio is close to 3, the

9

fatty acid yield can reach the theoretical value of 0.36g fatty acid/g glucose. In this case,

10

reduction of carbon loss via knock-out of competitive pathways will be effective to achieve the

11

theoretical yield (Figure 3.4A). If ATP consumption for maintenance increases, cells need to

12

“burn” extra carbon substrates for energy generation so that fatty acid yields drop significantly.

13

In this case, the biosynthesis optimization needs to reduce the loss of ATP/NADH. For example,

14

in a study of the engineered E.coli metabolism responding to fatty acid overproduction

15

MFA (via extensive flux calculation) found that the total ATP/NAD(P)H generation was much

16

higher than their consumption for biomass growth and fatty acid synthesis. Such difference was

17

attributed to the low P/O ratio and high cell maintenance during fatty acid overproduction.

18

Therefore, the engineered strain had a fatty acid yield of only 0.17g fatty acid/g glucose even

19

after extensive pathway engineering, (Figure 3.4B). The suboptimal energy metabolism in the

20

engineered strain was likely due to the various physiological stresses experienced by the cell

21

during fatty acid overproduction (e.g., change cell membrane integrity and compositions

22

Since metabolic stresses are commonly experienced by microbial hosts, 13C-MFA can provide a
48

143 13

, C-

144

).

1

diagnostic analysis of cell maintenance and offer insights into the metabolic potential for

2

improving biosynthesis 145.

3
4

Table 3.1: Simplified biochemical reactions considered in the model

5
Flux, v

Reactions

Note

v(1)

Glucose 2AceCoA + 2ATP + 4NADH

v(2)

AceCoA + 1.75NADPH + 0.875ATP  0.125 C16:0 fatty
acid

v(3)

AceCoA  2NADH + NADPH + ATP + FADH2

v(4)

NADH  NADPH

Transhydrogenation

v(5)

NADH  P/O ATP

v(6)

FADH2  0.67(P/O)ATP

Oxidative
phosphorylation
Oxidative
phosphorylation

v(7)

ATP ATP_ext

Glycolysis
Fatty acid synthesis
TCA cycle

ATP maintenance

6

6.6Glucose + 37.6ATP + 9.5NADPH + 2.5AceCoA=
Biomass formation
39.7Biomass + 3.1NADH
Note: glucose consumption for both biomass growth and product synthesis is normalized to 100.

7

The optimization was performed by a linear optimizer ‘linprog’ in MATLAB. The final yield (g

8

fatty acid/g glucose) is calculated as follows: Y=(v(2)/8∙256)/(100∙180) g C16:0 fatty acid/g

9

glucose.

v(8)

49

(A)

(B)

Figure 3.4: (A) Theoretical Yield as a function of P/O ratio and ATP maintenance without
biomass growth. (B) Theoretical Yield as a function of P/O ratio and ATP maintenance at growth
rate v(8)=3.6. The units of yield and ATP maintenance are ‘g C16:0 fatty acid/g glucose’ and
‘mol ATP /g glucose’ respectively. The infeasible range in the surface plot indicates that, energy
cannot be balanced for fatty acid or biomass production in that region, resulting in zero yield 143.

3.6 Product yield from unconventional engineered pathway
13

C-analysis can be used to decipher the yield of products through multiple biosynthesis

routes. For example, the acetogenic bacterium Clostridium carboxidivorans uses syngas (H2, CO
and CO2) to generate various chemicals (e.g., acetate, ethanol, butanol, and butyrate)

146

. It

contains several routes for CO2 fixation, which includes the Wood-Ljungdahl pathway and the
anaplerotic or the pyruvate synthase reactions.

13

C-experiments can be used to identify the

relative contribution of the different CO2 fixation pathways towards product synthesis. As a
demonstration, cultivation of Clostridium with labeled
50

13

CO2 and

12

CO has been shown in Fig.

3.5. Here,

13

C-analysis of the labeling patterns in either alanine or pyruvate can reveal the

relative contributions of the different CO2 assimilation routes to biomass and product synthesis.

Figure 3.5: 13C analysis to study the carbon assimilation during syngas fermentation (13CO2,
12
CO and H2). Analysis of metabolite labeling patterns can determine CO2 and CO utilization for
pyruvate production. The isotopomer data of pyruvate were used as a demonstration of 13C
applications for product yield calculations.
“Rule of Thumb” indicates that 20%~30% yield reduction happens per engineered
enzymatic reaction step

63, 128

. Thereby, novel pathways are constantly being explored and

engineered into microbial hosts to create a short-cut route from the feedstock to the final product.
If new pathways are engineered into microbes, it could be unclear how much the engineered
pathways are used by the microbe in parallel with its original pathway

147

. In the following

example, we demonstrate that 13C-experiments can determine the relative fluxes through multiple
51

pathways based on measurements of the product labeling. Specifically, butanol could be

Figure 3.6: Threonine and citramalate pathway for the synthesis of 1-butanol. The carbon
rearrangement network shows the labeling of 1-butanol for both the pathways, when fed with 113
C pyruvate and 13C bicarbonate.
produced simultaneously from a threonine pathway and a citramalate pathway (a short-cut keto
acid-mediated pathway) in E.coli

148

. If 1st position

13

C-pyruvate and

13

C-bicarbonate are fed to

the butanol producing strain, labeling patterns in butanol can quantify fluxes through the two
52

biosynthesis pathways (Fig. 3.6). In another example, James Liao Lab introduced a nonoxidative glycolytic cycle (NOG) into E.coli for breaking down hexose that could lead to a 50%
increase of biofuel yield

117

. This NOG pathway starts with fructose 6-phosphate and contains

three metabolic cycles to generate Acetyl-CoA without carbon loss. To probe the contribution of
NOG pathway to overall cell metabolism, their study has also presented a carbon rearrangement
map so that 13C-tools can be employed. These examples illustrates that 13C-analysis is potentially
suited to examine in vivo activity of these novel pathways for product synthesis.

3.7 Conclusion
Product yield is one of the main factors involved in commercialization of a
technology

149

. Microbial productivity is not only associated with the efficiency of biosynthesis

enzymes, but is also intertwined with energy metabolisms and metabolic balances 150. Via simple
13

C analysis, we can characterize the hosts’ intrinsic production yield using different carbon

sources, and determine the contributions of alternative pathways to biosynthesis. In addition,
13

C-MFA can profile hosts’ fluxomes and determine the amount of extra substrates that cell

metabolism has to consume to compensate ATP losses due to cell maintenance and low P/O
ratio. In the end, loss of products during fermentations (such as volatile alcohols or product
degradation) introduces common measurement errors and artifacts
quantification of unstable metabolites can also be achieved via
isotopomer labeled internal standards)

151

.

13

130, 136, 137

. The accurate

C-based method (i.e., using

Through this review paper, we hope that the

metabolic engineering field will recognize more value of 13C-techniques and foresee an extended
use of 13C-experiments during the development of microbial cell factories.
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Chapter 4: Metabolic engineering of Synechocystis
6803 for isobutanol production
This chapter has been reproduced from the following publication:
Varman, A.M., Xiao, Y., Pakrasi, H.B. & Tang, Y.J. Metabolic Engineering of Synechocystis sp.
Strain PCC 6803 for Isobutanol Production. Applied and Environmental Microbiology 79, 908914 (2013).

Abstract
Global warming and decreasing fossil fuel reserves have prompted great interest in the
synthesis of advanced biofuels from renewable resources. In an effort to address these concerns,
we have performed metabolic engineering of the cyanobacterium Synechocystis sp. PCC 6803 to
develop a strain that can synthesize isobutanol under both autotrophic and mixotrophic
conditions. With the expression of two heterologous genes from the Ehrlich Pathway, the
engineered strain can accumulate 90 mg/L of isobutanol from 50 mM bicarbonate in a gas-tight
shaking flask. This strain does not require any inducer (i.e., IPTG: Isopropyl β-D-1thiogalactopyranoside) or antibiotics to maintain its isobutanol production. In the presence of
glucose, isobutanol synthesis is only moderately promoted (titer = 114 mg/L). Based on
isotopomer analysis, we find that compared to the wild-type strain, the mutant significantly
reduced its glucose utilization and mainly employed autotrophic metabolism for biomass growth
and isobutanol production. Since isobutanol is toxic to the cells and may also be degraded
photochemically by hydroxyl radicals during the cultivation process, we employed in situ
removal of the isobutanol using oleyl alcohol as a solvent trap. This resulted in a final net
concentration of 298 mg/L of isobutanol under mixotrophic culture conditions.

55

4.1 Introduction
Global energy needs continue to increase rapidly due to industrial and development
demands, furthering environmental concerns.

Much of the worldwide energy consumption

comes from the burning of fossil fuels, which produces about 6 gigatons of CO2 annually

152

.

Increasing CO2 levels may act as a feedback loop to increase the soil emissions of other
greenhouse gases such as methane and nitrous oxide, heightening global temperature

153

. For

energy security and environmental concerns, there is an urgent demand for the development of
bioenergy. Bioethanol is the most common biofuel, but it also has low energy density and
absorbs moisture. Isobutanol (IB) is a better fuel because it is less water soluble and has an
energy density / octane value close to that of gasoline

154, 155

. Amongst the next generation

biofuels synthesized from pyruvate, IB possesses fewer reaction steps (5 reaction steps from
pyruvate to IB) in contrast to the synthesis of 1-butanol or biodiesel. IB is less toxic to microbes
25

so that it may achieve higher product titer and yield

63, 128

. For example, a maximum titer of

50.8 g/L of IB can be achieved in an engineered E. coli 130.
On the other hand, cyanobacteria can not only convert CO2 into bio-products, but also
can play an important role in environmental bioremediations. The photosynthetic efficiency of
cyanobacteria (3~9%) is high compared to higher plants (≤0.25~3%)

1, 13

. Furthermore, some

species of cyanobacteria are amenable to genetic engineering. Table 4.1 lists the various biofuels
that have been synthesized through the metabolic engineering of cyanobacteria. Autotrophic IB
production in cyanobacteria was first demonstrated in Synechococcus 7942

28

.

Moreover, a

model cyanobacterium Synechocystis sp. PCC 6803 is capable of growing under both
photoautotrophic and mixotrophic conditions, while the presence of glucose can significantly
56

promote biomass and bioproduct synthesis

156

. Thereby, we have engineered a glucose tolerant

Synechocystis 6803 strain with two key genes kivd and adhA of the Ehrlich pathway26 so that the
cyanobacterial strain can convert CO2 into IB. Through both metabolic engineering and
bioprocess optimization, we have improved our strain’s IB production capabilities.

4.2 Materials and methods
4.2.1 Chemicals and reagents.
Restriction enzymes, T4 DNA ligase, DNase and a Revertaid first strand cDNA synthesis
kit were purchased from Fermentas or New England Biolabs. Oligonucleotides were purchased
from Integrated DNA Technologies. Toluene, IB, α-ketoisovaleric acid, phenol and chloroform
were purchased from Sigma-Aldrich (St. Louis, MO). KlenTaq-LA 157 was purchased from DNA
Polymerase Technology (St. Louis, MO). TRI Reagent® was purchased from Ambion, USA. 13C
labeled glucose was purchased from Cambridge Isotope Laboratories.
4.2.2 Culture medium and growth conditions.
A glucose tolerant wild-type strain of Synechocystis 6803 (WT) and the recombinant
strain AV03 were grown at 30°C in liquid BG-11 medium or solid BG-11 medium at a light
intensity of 50 µmol of photons m-2s-1 in ambient air. Kanamycin at a concentration of 20
µg/mL was added to the BG-11 medium when required. Growth of the cells was monitored by
measuring OD730 of the cultures on an Agilent Cary 60 UV-Vis Spectrophotometer. Cultures for
the synthesis of IB were grown in 10 mL medium (Initial OD730 of 0.4) in 50 mL shake flasks for
4 days. The mid-log phase cultures were then closed with rubber caps to prevent the loss of IB
during incubation, and the cultures were supplemented with 50 mM NaHCO3 as an inorganic
carbon source. Mixotrophic cultures of Synechocystis 6803 were started in a BG-11 medium
57

containing a known amount of glucose as an organic carbon source. E. coli strain DH10B was
the host for all plasmids constructed in this study. E. coli cells were grown in falcon tubes
containing Luria-Bertani (LB) medium at 37°C under continuous shaking. Ampicillin (100
µg/mL) or kanamycin (50 µg/mL) was added to the LB medium when required, for the
propagation of plasmids in E. coli.
4.2.3 Plasmid construction and transformation of Synechocystis 6803.
The vector pTAC-KA containing an ampicillin resistance cassette (AmpR) and two genes
(kivd and adhA from Lactococcus lactis) was constructed as described 129. The pTAC-KA vector
was modified using the following steps to convert it into a Synechocystis 6803 vector. To clone
the flanking regions of a potential neutral site into pTAC-KA, a Synechocystis 6803 vector
pSL2035 containing both the flanking regions and the kanamycin resistance cassette (KmR) was
used as a template. pSL2035 is a Synechocystis 6803 vector designed to integrate any foreign
DNA into the genome of Synechocystis 6803 by replacing the psbA1 gene and its promoter.
psbA1 is a member of psbA gene family and is found to be silent under most conditions

158, 159

.

pSL2035 was constructed by cloning the flanking regions for the psbA1 gene and the KmR into
pUC118. The 5’ flanking region from pSL2035 was PCR amplified along with KmR by
respective primers (Table 4.2) and cloned into the PciI and Bsu36I site of pTAC-KA, resulting in
the vector pTKA2. The 3’ flanking region was PCR amplified from pSL2035 by the respective
primers and inserted into the AhdI site of pTKA2, disrupting the native AmpR and henceforth
creating the vector pTKA3.
Transformation was performed by using a double homologous recombination system, and
the genes were integrated into the target site of the Synechocystis genomic DNA. Specifically, 2
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mL of Synechocystis 6803 from a mid-log phase (1~3×108 cells mL-1) culture was centrifuged at
10,000 × g for 2 min. The pellet was suspended in a fresh BG-11 medium (200 µL) to a final cell
density of 1~3×109 cells mL-1. Plasmid DNA was added to a final DNA concentration of 5~10
µg/mL 19 to this dense Synechocystis 6803 cell culture. The mixture was then incubated under
normal light conditions (50 µE m-2 s-1) overnight. The culture was then spread onto a BG-11 agar
plate containing 20 µg/mL of kanamycin. Recombinant colonies usually appear between 7 and
10 days. Colonies were propagated on a fresh BG-11 plate containing kanamycin, and a colony
PCR was performed to verify successful integration of the insert into the genomic DNA of the
recombinant. The positive colonies were propagated continuously onto BG-11 plates containing
kanamycin, to get a high segregation of the insert in the recombinant 17. To verify the integrity of
the promoter and gene sequences, the heterologous DNA integrated into the genome of the
mutant AV03 was PCR amplified and sent for sequencing with the respective primers.
4.2.4 Reverse transcription PCR (RT-PCR).
Total RNA isolation of Synechocystis 6803 was performed using a TRI Reagent®
(Ambion, USA) by following the manufacturer protocol with modifications. 1 mL of RNAwiz
was prewarmed to 70°C and pipetted into the frozen cells directly. Immediately, the mixture was
vortexed and incubated for 10 min at 70°C in a heater block. 0.2 mL of chloroform was added to
the mixture and mixed vigorously followed by incubation at room temperature for 10 min. The
aqueous and the organic phase were separated by centrifugation at 10,000 × g at 4°C. The RNA
containing aqueous phase was transferred into an eppendorf tube, to which, equal volumes of
phenol and chloroform were added. The mixture was mixed vigorously followed by
centrifugation to separate the aqueous and the organic phase. The aqueous phase was removed to
a clean tube, to which 0.5 mL of diethyl pyrocarbonate (DEPC) treated water was added. RNA
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in the solution was precipitated by the addition of room temperature isopropanol and centrifuged
at 10,000 × g at 4°C to pellet the RNA. The RNA was washed with ethanol and resuspended in a
fresh 50 µL of DEPC treated water.

The quantity and quality of the isolated RNA was

determined using a Nanodrop ND-1000 (Thermo Scientific, USA). The RNA was incubated at
room temperature with DNase to degrade any genomic DNA, if present in the RNA sample.
Synthesis of cDNA was performed by utilizing a Reverse transcriptase enzyme from Fermentas
along with dNTPs and random primers in a reaction buffer. The mixture was incubated at 42°C
for 60 min. The synthesized cDNA was used as a template for the PCR, to detect the expression
of the mRNA of interest.
4.2.5 Isobutanol quantification assay.
IB synthesized in the culture was quantified using a gas chromatograph (Hewlett Packard
model 7890A, Agilent Technologies, equipped with a DB5-MS column, J&W Scientific) and a
mass spectrometer (5975C, Agilent Technologies). IB extraction was done using a modified
procedure 118. Samples of the cyanobacterial culture (400 µL) were collected and centrifuged at
10000 × g for 5 min. IB was extracted from the supernatant by vortexing for 1 min with 400 µL
of toluene, and methanol was used as the internal standard. A 1 µL sample of the organic layer
was injected into the gas chromotagraph (GC) with helium as the carrier gas. The GC oven was
held at 70°C for 2 min and then raised to 200°C with a temperature ramp of 30°C min-1, and the
post run was set at 300°C for 6 min. The range of the mass spectrometer (MS) scan mode was set
between m/z of 20 and 200. The concentration of IB present in the culture was determined based
on a calibration curve prepared with known concentrations of IB ranging from 25 mg/L to 400
mg/L.
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4.2.6 13C-experiment to detect carbon contribution of glucose.
The

13

C-abundance of some important metabolites was measured for both the wild-type

and the mutant strain AV03, to estimate the carbon contribution of both glucose (fully labeled by
13

C) and nonlabeled bicarbonate for biomass and IB synthesis. Mixotrophic cultures of both the

wild-type Synechocystis 6803 and the mutant AV03 were grown in BG-11 medium (with 50mM
nonlabeled NaHCO3), which contained 0.5% glucose (U-13C, Cambridge Isotope Laboratories,
MA). Cultures were collected on day 3, 6 and 9, and proteinogenic amino acids were hydrolyzed
and then derivatized with TBDMS (N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide,
Sigma-Aldrich). The derivatized amino acids were analyzed for their mass isotopomer
abundance by GC-MS, as described before

160, 161

the entire amino acid, was used to calculate the

. The m/z ion [M-57]+, which corresponds to

13

C abundance in amino acids [m0 m1…. mn].

The fraction of carbon (FA) derived from fully labeled glucose for each amino acid was estimated

∑i =1 i × mi
=
n

based on the following equation: F A

n

(4.1)

where i is the number of labeled carbons, mi is the mass fraction for different isotopomers of the
corresponding amino acid and n represents the total number of carbons in the corresponding
amino acid. The m/z of [M-15]+ was used only for leucine and isoleucine, since their [M-57]+
overlaps with other mass peaks

162

. IB extraction was performed for samples obtained from the

above cultures and was analyzed using the GC-MS. The fraction of carbon derived from glucose
for isobutanol (FIB) was estimated based on the isobutanol MS peak abundances:

∑ i × Ai
FIB = i =14
4∑ Ai
i =0
4

(4.2)
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where Ai is the abundance of the mass-to-charge ratio peaks for the various isobutanol
isotopomers (i.e., A0~A4 for m/z=74~78).

4.3 Results
4.3.1 Construction of an isobutanol producing Synechocystis 6803 strain.
IB synthesis in Synechocystis 6803 requires the expression of two heterologous genes of
the Ehrlich pathway. The enzymes 2-keto-acid decarboxylase and alcohol dehydrogenase can
convert 2-keto acids into alcohols. In this work, we constructed a plasmid pTKA3 containing the
genes kivd and adhA from Lactococcus lactis under the control of an IPTG inducible promoter,
Ptac. The plasmid was designed to integrate the genes into a neutral site in the genome of
Synechocystis 6803, along with a kanamycin resistance cassette (Fig. 4.1a - Left). The wild-type
strain of Synechocystis 6803 was transformed with pTKA3, resulting in the recombinant strain
AV03. The integration of the insert genes into the genome was verified by a colony PCR after
several rounds of segregation (Fig. 4.1a - Right).
To identify the optimal IPTG concentration required for IB synthesis, the AV03 strain
was grown under different concentrations of IPTG. IB analysis from the cultures indicated that
IB was highly synthesized even without the addition of IPTG (Fig. 4.1b). To verify if this
observation was an artifact of any mutations that might have occurred in lacI or the promoter, the
foreign DNA integrated into the chromosome of AV03 was sequenced. Sequencing results for
the lacI and the promoter Ptac in the genome of AV03 revealed that the nucleotide sequence was
completely intact. There have been reports of leaky expressions with IPTG inducible promoters
163

. Besides, Fig. 4.1b indicates that as the concentration of IPTG went higher than 1mM, the IB

synthesis reduced. The OD730 of the different cultures indicated that the addition of IPTG did
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not apparently interfere with the growth rate of the culture. RT-PCR showed the expression
levels of the genes kivd and adhA under different IPTG concentrations. The result of RT-PCR
experiment (Fig. 4.1b - Inset) indicated that the levels of kivd and adhA mRNA synthesized in
the mutant were higher with IPTG than without. Henceforth, lower expression of the two genes
is sufficient for IB synthesis, possibly because the Ehrlich pathway may not be the rate-limiting
step for IB production.
4.3.2 Isobutanol synthesis under autotrophic and mixotrophic growth.
Under autotrophic conditions, Synechocystis 6803 utilizes light as an energy source (ATP
and NADPH) for the conversion of CO2 into biomass and IB. Fig. 4.2a compares the autotrophic
growth of the mutant and the wild strain. Under autotrophic conditions, we found that the growth
rate of the mutant AV03 remains unaltered as compared to the wild-type strain. IB accumulation
in the mutant was tested under autotrophic condition (Fig. 4.2b), and the strain was found to
synthesize a maximum of 90 mg/L of IB (the only extracellular product detected by GC-MS) in a
6-day culture. In a sealed shaking flask, NaHCO3 in the medium (50mM) was consumed by
AV03 within six days, and then both the biomass and IB started declining.
The wild-type strain of Synechocystis 6803 grows about 5 times faster under mixotrophic
conditions compared to autotrophic conditions (Fig. 4.2a). However, our mutant AV03 did not
exhibit an increased growth rate under mixotrophic conditions. To measure the glucose
utilization by wild-type and mutant AV03, we fed cells with 0.5% fully labeled glucose and
nonlabeled bicarbonate. Isotopomer analysis of

13

C-abundance in cell metabolites (Fig. 4.2c)

showed that the wild-type synthesized 70~90% of its amino acids using carbons from glucose,
whereas the mutant produced biomass only using 5~10% carbon from glucose, and 12% of the
carbon of IB was labeled (i.e., derived from glucose). These results indicated that the mutant
63

tended to limit glucose metabolism for IB production. The AV03 strain was found to synthesize
a maximum of 114 mg/L of IB mixotrophically after 9 days (Fig. 4.2b), whereas cells with only
glucose (heterotrophic without bicarbonate or CO2) synthesized a maximum of 27 mg/L of IB.
This result suggests that the Synechocystis 6803 mutant is unable to take significant advantage of
its glucose metabolism to have a fast rate of IB production.
4.3.3 In situ alcohol concentrating system using a solvent trap.
IB is toxic to the cells and our study revealed that IB inhibited Synechocystis 6803 growth
at external concentrations of only 2 g/L (Fig. 4.3). Moreover, our control experiments indicated
the loss of IB after 9 days of continuous incubation. IB can be slowly degraded by photochemically-produced hydroxyl radicals in aerobic cyanobacterial cultures

164-166

. Therefore, a

system with continuous removal of the synthesized alcohol products will be beneficial 167, 168. We
have demonstrated the use of an in situ alcohol removal system by using oleyl alcohol 169, 170 as a
solvent trap for increasing IB titer. In previous studies, gas stripping is one efficient way for IB
recovery, but it requires an expensive cooling system due to very low concentrations of IB from
photo-bioreactors. Here, inside each cultivation flask, we placed a small glass vial containing 0.5
or 1 mL oleyl alcohol solvent, so that oleyl alcohol was not mixed with the culture solution (Fig.
4.4). Volatile IB in the headspace can be trapped in the solvent vial because of the high
solubility of IB in oleyl alcohol. This method will effectively trap the IB while the solvent will
not directly interfere with light and cell culture conditions.
To test the effect of oleyl alcohol on IB productivity, we did a 3-week time-course study
(Fig. 4.4) by adding 50 mM NaHCO3 intermittently (every 4 days). During the cultivation, the
pH of the cultures was also adjusted to be between 8 and 9 before the addition of excess
bicarbonate. Every 3 days, the oleyl alcohol in the vials was taken out for IB measurement, and
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then replaced with fresh oleyl alcohol. The mixotrophic cultures with alcohol trap (0.5 mL)
reached the highest net IB concentration of 298 mg/L. The autotrophic cultures with 0.5 mL and
1 mL oleyl alcohol had a maximum net IB titer of 180 mg/L and 240 mg/L, respectively,
whereas the autotrophic cultures without the oleyl alcohol trap were able to achieve a maximum
of only 108 mg/L of IB. IB levels in the organic phase reached concentrations of up to 500 mg/L
with only 3 days of trapping.

4.4 Discussion
Isobutanol (IB) is a promising biofuel for the replacement of gasoline. So far, E. coli has
remained the most successful microbial host for IB production. In this study, we have focused
our efforts on a cyanobacterial species, Synechocystis 6803, which can grow on both CO2 and
glucose. The mixotrophic cultivation may offer industrial flexibility and economic benefits
because the gas-liquid mass transfer of CO2 is often a rate-limiting step in efficient
photobioreactor operations. Attempts in creating a stable strain of Synechococcus 7942 that can
transport and utilize glucose has been barely successful

171

. The glucose tolerant strain of

Synechocystis 6803 unlike other cyanobacterial strains, can perform both autotrophic and
mixotrophic metabolisms. In our work, we found that the wild-type strain of Synechocystis 6803
under mixotrophic conditions grew at a rate 5 times faster than the autotrophic condition.
Moreover, the engineered Synechocystis 6803 strain accumulated 90 mg/L of IB, whereas the
Synechococcus 7942 strain expressing the same two enzymes (keto-acid decarboxylase and
alcohol dehydrogenase) only accumulated a maximum of 18 mg/L

28

. Switching the condition

from autotrophic to mixotrophic for the mutant AV03 increased the maximum IB titer to 114
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mg/L. Interestingly, the mutant tended to grow autotrophically and had minimal glucose
utilization compared to the wild-type strain (Fig 4.2c).
IB can be inhibitory to cell physiologies. Moreover, our experiments also observed IB
degradation (by hydroxyl radicals) during the incubation process. Thereby, efforts in coming up
with product recovery are important to improve IB titer in cyanobacterial culture. This work
employed an in situ IB removal system by growing cultures in shake flasks with vials containing
oleyl alcohol. Mixotrophic growth of AV03 along with in situ IB removal synthesized a
maximum of 298 mg/L IB, which is lower than the highest IB titer (450 mg/L) reported in
Synechococcus 7942 mutant expressing 3 more genes of the keto acid pathway. On the other
hand, our strain design has two apparent advantages for industrial application. First, our strain
does not require any antibiotics to maintain its IB production because the two heterologous genes
in the mutant show good stability during normal cultivation conditions. Second, the strain does
not need any inducer (IPTG) for IB production, which can significantly reduce the industrial
costs.
Overexpressing the keto acid pathway can increase the IB titer in Synechococcus 7942 28.
Furthermore, optimizing CO2 and light conditions of the cyanobacterial strain can also increase
the final titer and productivity. Liu et. al.,

172

have reported a doubling time of 7.4 hours for

Synechocystis 6803, by growing them under 140 µmol of photons m-2 s-1 of light and by
bubbling 1% CO2 enriched air. Therefore, our strain can serve as a springboard for future
development of higher performance Synechocystis 6803 strains with increased IB titer and
productivity.
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In summary, IB synthesis under autotrophic conditions in a cyanobacterium
Synechocystis 6803 was demonstrated by the expression of two heterologous genes. It was
further demonstrated that mixotrophic cultures of the mutant can significantly increase IB
synthesis with minimal glucose consumption. The mechanism behind the reduced glucoseutilizing metabolism of AV03 compared to the wild-type strain remains unclear. A possible
explanation is that the cells tend to avoid the intracellular metabolic imbalance or IB
intermediate inhibition by down-regulating glucose uptake. Using oleyl alcohol as a simple
solvent trap, IB production can be improved by 2~3 times. Therefore, in situ IB recovery may
reduce the product loss and separation cost. We have also demonstrated that a simple expression
of the Ehrlich pathway with bioprocess modification can synthesize IB without other major
waste products, while still achieving comparable levels of IB to an extensive genetically
modified Synechococcus 7942 strain (Table 4.1) 28.
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Figure 4.1a

Figure 4.1b

1

2

3

4

Figure 4.1: (a) Schematic representation to show the integration of the genes kivd and adhA
into the genome of Synechocystis 6803. Colony PCR performed to verify the integration of the
insert into the genomic DNA of the mutant (AV03). The vector ptka3 w was used as a template
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for the positive control and wild-type cells were used as negative control. Colony PCR of AV03,
showed the presence of a band (8.3kb) the same size as the positive control (+ve) and the
absence of the negative control (WT) band. (b) IB synthesized by engineered Synechocystis 6803
under different IPTG concentrations (n=3). (Inset) Result of an RT-PCR performed to detect the
expression of the heterologous genes kivd (Top: 500bp from kivd) and adhA (Bottom: 200bp
from adhA). Lane 1, wild-type 6803 (WT); Lane 2, AV03 with 0 mM IPTG; Lane 3, AV03
with 0.5mM IPTG; Lane 4, AV03 with 1mM IPTG.

Figure4. 2a

Figure4. 2b
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Figure 4.2c

Figure 4.2: (a) Growth curves of Synechocystis 6803 WT and AV03 (n=3, shake flask cultures):
◊ WT under autotrophic, ♦ WT under mixotrophic, ○ AV03 under autotrophic and ● AV03
under mixotrophic conditions (note: growth curve of AV03 under mixotrophic condition
overlaps with autotrophic growth curves of AV03 and WT). (b) IB synthesized in AV03 under
autotrophic conditions (only HCO3), heterotrophic (only glucose) and mixotrophic (both HCO3
and glucose) conditions (n=3, shake flask cultures with closed caps). (c) Percentage carbon
contribution of glucose for synthesizing amino acids and isobutanol in the wild-type (WT) and
the mutant strain (AV03) as measured on day 9 (shake flask cultures with closed caps).
Isotopomer analysis (TBDMS based method) of proteinogenic amino acids confirms the low 13Cglucose utilization by the mutant. The error bar represents the 2% technical error of the
instrument.
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Figure 4.3

Figure 4.3: Toxic effects of IB on the growth of Synechocystis 6803. IB was added to a final
concentration (g/L, n=2) of ◊ 0, □ 0.2, Δ 0.5, ○ 1, ■ 2 and ● 5 to a Synechocystis 6803 culture
with an initial OD730 ~ 0.8.
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Figure 4.4

Figure 4.4: Net concentration of IB synthesized (columns) and biomass growth (curves) by the
AV03 culture under different conditions (n=3). a – IB with 0.5 mL oleyl alcohol (Autotrophic); b
– IB with 1 mL oleyl alcohol (Autotrophic); c – IB with 0.5 mL oleyl alcohol and glucose
(Mixotrophic); d – IB with no oleyl alcohol (Autotrophic, negative control); a1 – OD730 with 0.5
mL oleyl alcohol (Autotrophic); a2 – OD730 with 1 mL oleyl alcohol (Autotrophic); a3 – OD730
with 0.5 mL oleyl alcohol and glucose (Mixotrophic); a4 – OD730 with no oleyl alcohol
(Autotrophic, negative control). (Inset) Schematic representation of the in situ IB removal
system used to increase the production of IB.
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Table 4.1: Metabolic engineering of cyanobacterial strains for biofuel production.
Product

Species

Ethanol

Synechococcus
7942
Synechocystis
6803
Synechococcus
7942
Synechococcus
7942
Synechococcus
7942
Synechocystis
6803
Synechocystis
6803
Synechocystis
6803
Synechococcus
7942

Ethanol
Isobutyrald
ehyde
Isobutanol
Isobutanol
Fatty
alcohol
Alkanes
Fatty acids
Hydrogen

1-Butanol
Fatty
alcohol
1-Butanol

Synechococcus
7942
Synechocystis
6803
Synechococcus
7942

Overexpressed
genes
pdc and adh

Promoters

Culture vessel / Remarks

rbcLS

Shake flask

552 mg/L

pdc and adh

psbA2

Photobioreactor

6 days

21

1100 mg/L

alsS, ilvC, ilvD, kivd
and rbcls
kivd and yqhD

LlacO1 , trc and
tac
trc

Roux culture bottle with
NaHCO3
Shake flask with NaHCO3

8 days

28

1 day

28

alsS, ilvC, ilvD, kivd
and yqhD
far

LlacO1 , trc

Shake flask with NaHCO3

6 days

28

rbc

Photobioreactor with 5% CO2

18 days

30

accBCDA

rbcl

Shake flask

-

30

tesA, accBCDA,
fatB1, fatB2, tesA137
hydEF, hydG and
hydA

psbA2, cpc, and
trc
psbA1, lac

1% CO2 bubbling

17 days
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-

32

hbd, crt, adhE2, ter
and atoB
far, aas

trc, LlacO1

7 days

29

rbc, psbA2

Dark roux culture bottle under
anoxic condition
Shake flask

-

174

ter, nphT7, bldh,
yqhD, phaJ, phaB

trc, LlacO1

Shake flask

18 days

175

18 mg/L
450 mg/L
200±8 µg/L
162±10
µg/OD/L
197 ±14 mg∕L
2.8
µmol/hr/mg
Chl-a*
14.5 mg/L
20 ± 2
µg/L/OD
30 mg/L

where *Chl-a is chlorophyll a; **DCMU is 3-(3,4-dichlorophenyl)-1,1-dimethylurea.
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Anaerobic conditions with
DCMU treatment**

Culture
Days
28 days

Ref.

Titer or
Productivity
230 mg/L
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Table 4.2: Primer sequences used in this study.
Name
AMV14F
AMV15R
AMV16F
AMV17R
ps1_up_fwd
AMV01
AMV12
AdhA-TMs
adhA_RTr
Rnpbr
Rnpbf
AV03_6F
AV03_4R
AV03_1R
AV03_2F
AV03_3F
AV03_4F
AV03_2R
AV03_5F
AV03_7F
AV03_8F
AV03_5R

Sequence (5’→3’)
GCGCACATGTCGGAACAGGACCAAGCCTTGAT
GCGC CCTGAGGCCTTTACCATGACCTGCAGGG
GCGCGACGGGGAGTCAATTGTGCCATTGCCATAACTGCTTTCG
GCGCGACTCCCCGTCTTTGACTATCCTTTTTAGGATGGGGCA
TACCGGAACAGGACCAAGCCTT
GCGCCATATGTATACAGTAGGAGATTACCTATTAGAC
GCAGCAGCAACATCAACTGGTAAG
TCAACTAGTGGTACCAGGAGATATAATATGAAAGCAGCAGTAGTAAG
GACAATTCCAATTCCTTCATGACCAAG
CGGTATTTTTCTGTGGCACTGTCC
CAGCGGCCTATGGCTCTAATC
GAATCCGTAATCATGGTCATAGCTG
GCCAAAGCTAATTATTTCATGTCCTGT
TGTCGGGGCGCAGCCATGA
AGAGGATCCTTCTGAAATGAGCTG
CAGAGCCTAATCTTAAAGAATTCGTGG
GGGTAAACTATTTGCTGAACAAAATAAATC
CCGCTTCTGCGTTCTGATTTAATC
GTTGATCGGCGCGAGATTTAATCG
CCGTTGAAATTGACCGAGTACTTTCT
CAGTCGAAAGAGAAATTCATGGACC
CGCTACGGCGTTTCACTTCTG
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Chapter 5: Photoautotrophic production of D-lactic acid in
an engineered cyanobacterium
This chapter has been reproduced from the following publication:
Varman, A.M., Yu, Y., You, L., & Tang, Y.J. Photoautotrophic production of D-lactic acid in an
engineered cyanobacterium. Microbial Cell Factories, 12, 117 (2013).
AMV and YY contributed equally for this work.

Abstract
Background: The world faces the challenge to develop sustainable technologies to replace
thousands of products that have been generated from fossil fuels. Due to concerns about food
security, sugar-based microbial fermentation raises economical questions. Thus, phototrophic
microbial cell factories serve as promising alternatives for the production of commodity
chemicals and biofuels. For example, polylactic acid (PLA) with its biodegradable properties is a
sustainable, environmentally friendly alternative to polyethylene. At present, PLA microbial
production is mainly dependent on food crops such as corn and sugarcane. Moreover, optically
pure isomers of lactic acid are required for the production of PLA, where D-lactic acid controls
the thermochemical and physical properties of PLA. Henceforth, production of D-lactic acid
through a more sustainable source (CO2) is desirable.

Results: We have performed metabolic engineering on the cyanobacterium, Synechocystis sp.
PCC 6803, for the phototrophic synthesis of optically pure D-lactic acid from CO2 by utilizing
solar energy. Synthesis of optically pure D-lactic acid was achieved by utilizing a recently
discovered enzyme, (i.e., a mutated glycerol dehydrogenase, GlyDH*).

Significant

improvements in D-lactate synthesis were achieved through codon optimization and by
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balancing the cofactor (NADH) availability through the heterologous expression of a soluble
transhydrogenase (STH). We have also discovered that addition of acetate to the cultures
improved lactic acid production. More interestingly,

13

C based metabolic pathway analysis

revealed that acetate was not used for the synthesis of lactic acid, but was mainly used for
synthesis of some biomass building blocks (such as leucine and glutamate). Finally, the optimal
strain was able to accumulate 1.14 g/L (photoautotrophic condition) and 2.17 g/L (phototrophic
condition with acetate) of D-lactate in 24 days.
Conclusions: We have demonstrated the photoautotrophic production of D-lactic acid by
engineering a cyanobacterium, Synechocystis 6803. The engineered strain shows an excellent Dlactate productivity from CO2. In the late growth phase, the lactate production rate by the
engineered strain reached a maximum of 0.19 g D-lactate/L/day (in the presence of acetate). This
study serves as a good complement to the recent engineering work done on Synechocystis 6803
for L-lactate production. Thereby, our study may facilitate developments in the use of
cyanobacterial cell factories for the commercial production of high quality PLA.
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5.1 Background
Fossil fuels helped literally ignite the industrial revolution, and from then on radically
changed the way we live; today, thousands of products are generated from fossil fuels

176

.

Unfortunately, fossil fuels are non-renewable and their reserves will foreseeably run dry.
Moreover, the reckless use of this resource has resulted in a tremendous release of greenhouse
gases leading to adverse effects to our earth’s climate and to the creatures living on our planet.
These drawbacks have driven researchers to look for alternative renewable replacements for
petroleum and petroleum-derived products.

Amongst the petroleum-derived products;

polyethylene with an annual productivity of 80 million metric tons per annum stands out as one
of the most commonly used plastics 177. Polylactic acid (PLA) is made by the polymerization of
lactic acid and has the potential to replace polyethylene as a biodegradable alternative 178. Lactic
acid is a chiral compound and exists in two isomeric forms: D (-) lactic acid and L (+) lactic acid.
The various properties of polylactic acid are modulated by the mixing ratio of the D (-) and L (+)
lactic acid and, henceforth, it is essential to produce both the isomers

179

. It has been estimated

that for the PLA production to be profitable, the lactic acid price should be less than 0.8$/kg 180.
This necessitates the production of lactic acid from a cheaper source. Although microbial
fermentation can produce lactate from sugar-based feedstock, such process may compete with
global food supplies. Therefore, this work focuses on cyanobacterial process development for the
sustainable synthesis of D (-) lactic acid, with CO2 as the carbon substrate and sunlight as an
energy source.
Cyanobacteria have the ability to reduce atmospheric CO2 into useful organic
compounds by using solar energy and have been engineered to synthesize a number of value77

added products

28, 29, 181, 182

. Synechocystis sp. PCC 6803 (hereafter Synechocystis 6803) with its

ability to uptake foreign DNA naturally, has been the model organism of choice for various
metabolic engineering works

135, 183, 184

.

mixotrophically with glucose and acetate

Synechocystis 6803 also has the ability to grow
185

. Therefore, along with CO2, its versatile carbon

metabolism allows the co-utilization of cheap organic compounds for product biosynthesis. For
example, acetate abundant wastewater generated from biomass hydrolysis and anaerobic
digestion

131

, can be potentially used for promoting cyanobacterial productivity. More

importantly, there are numerous molecular biology tools for Synechocystis 6803, making it an
attractive organism for metabolic engineering works 163, 186.
Synechocystis 6803 has recently been engineered for the production of L-lactate (a
maximal titer of 1.8 g/L and a maximal productivity of 0.15 g/L/day)

187-189

.

However,

engineering Synechocystis 6803 for the production of optically pure D-lactate synthesis is more
difficult due to the lack of an efficient D-lactate dehydrogenase. Recently, a mutated glycerol
dehydrogenase (GlyDH*) was discovered by Wang et al.

190

and this enzyme was found to

behave as a D-lactate dehydrogenase, exhibiting an unusually high specific activity of 6.9 units
per mg protein with pyruvate and NADH as substrates. This enzyme allows a Bacillus coagulans
strain to produce 90g/L of D-lactate. Their work served as a motivation for us to engineer
Synechocystis 6803 through the heterologous expression of gldA101 (encodes GlyDH*). We
found that this original enzyme was able to synthesize optically pure D-lactate in Synechocystis
6803. To further improve cyanobacterial productivity, we employed three strategies: 1. Codon
optimization of gldA101 (Supplementary Figure 5.5); 2. Heterologous expression of a
transhydrogenase; 3. Supplementing cultures with extracellular carbon sources (such as glucose,
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pyruvate and acetate). The final engineered strain demonstrated a high D-lactic acid productivity
and titer (titer >1g/L).

5.2 Results and Discussion
Cyanobacteria need a lactate dehydrogenase to synthesize lactate from pyruvate (Figure
5.1). Earlier works on Synechocystis 6803 for lactate production involved the expression of an
ldh from Bacillus subtilis for synthesis of L-lactate
GlyDH* for D-lactate production

190

188

. As a first step, we tested the activity of

by transferring the gene from Bacillus coagulans to

Synechocystis 6803. A plasmid pYY1 was constructed that contained the gene gldA101 under
the control of an Isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible promoter, Ptrc. The
gldA101 gene was then subsequently transferred to the glucose tolerant wild type Synechocystis
6803 through natural transformation, generating the strain AV08. The optical density and the Dlactate concentration of the AV08 cultures were monitored in shake flasks. As can be verified
from Figure 5.2, AV08 did not show any significant levels of D-lactate in the initial 12 days.
The D-lactate levels started increasing steadily at the late autotrophic growth phase and reached a
final titer of 0.4 g/L, whereas a wild type strain of Synechococcus 7002 was able to produce only
~ 7 mg/L of D-lactate through glucose fermentation 191.
A familiar strategy to increase the synthesis of a target product would be to increase the
levels of the heterologous enzyme inside the cell. This can be achieved by modifying the
enzyme regulation either at the transcriptional level or at the translational level. Cyanobacteria
are known to have their own preference in the use of codons for synthesizing amino acids
Lindberg et al.

193

192

.

have employed codon optimization for the isoprene synthase gene IspS and

have found a 10-fold increase in the IspS expression level. More recently, this strategy was
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applied to increase the expression of the efe gene (from Pseudomonas syringae) in Synechocystis
6803 for ethylene production

194

. Since the gene involved in this work was borrowed from a

gram-positive organism and Synechocystis 6803 being gram-negative, we hypothesized that this
would be a useful strategy. The codon optimized gene gldA101-syn (synthesized by Genewiz
Inc, South Plainfield, NJ) was integrated into the psbA1 gene loci in the genome of the WT
Synechocystis 6803 using the plasmid pDY3 to obtain the strain AV11.
Further improvements in product synthesis can be achieved by rectification of
bottlenecks in the metabolic pathway. The lactate dehydrogenase enzyme utilizes NADH as its
cofactor, whereas the ratio of NADH to NADPH is reported to be much lower in cyanobacteria.
For example, the ratio of NADH to NADPH in Synechococcus 7942 under light conditions was
estimated to be 0.15, and in Synechocystis 6803 under photoautotrophic conditions the
intracellular NADH concentration was only 20 nmol/g fresh weight, whereas the intracellular
concentration of NADPH was about 140 nmol/g fresh weight 195-197. This lower concentration of
NADH in cyanobacteria, points to the fact that availability of NADH could be a major limiting
factor for synthesizing D-lactate. Henceforth, a soluble transhydrogenase, sth from Pseudomonas
aeruginosa 198, was introduced downstream of the gene gldA101-syn. This engineered strain was
called AV10. The heterologous genes in AV10 and AV11 are under the control of the same
single promoter, Ptrc, located upstream of gldA101-syn and sth in AV10 and located upstream of
gldA101-syn in AV11.
The three strains (AV08, AV10 and AV11) showed similar growth rates to wild type
strain under photoautotrophic conditions, and thus the production of D-lactate did not introduce
growth defects in the engineered strains (Figure 5.2A and Figure 5.6). However, the three strains
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differed in the production rate of D-lactic acid. The strain AV11 with codon optimization
(gldA101-syn) had an improved productivity for D-lactate compared to the AV08 strain (Figure
5.2B). Both strains produced D-lactate mainly during the later growth stage. Introduction of the
transhydrogenase improved the D-lactate synthesis further in AV10, and this strain produced Dlactate in both the growth phase and non-growth phase. The rate of photoautotrophic D-lactate
production by AV10 increased significantly (achieving a maximum productivity of 0.1 g/L/day
and ~0.2 mmol/g cell/day) during the late phase of the culture and the final titer of D-lactate
reached 1.14 g/L.
We observed that the D-lactate production rate reached its peak in the later stages of
cultivation, suggesting that more carbon flux has been directed to lactate production during the
non-growth phase. This increased flux was expected because the lactate precursor (pyruvate) is a
key metabolic node occupying a central position in the synthesis of diverse biomass components,
and more pyruvate becomes available for lactate synthesis when biomass growth becomes slow.
Therefore, an obvious thought would be to enhance lactate production by supplementing the
cultures with pyruvate

199

. However, our experiments found that addition of pyruvate did not

yield apparent improvements in D-lactate synthesis (data not shown), possibly because
Synechocystis 6803 may lack an effective pyruvate transporter. The alternate option would be to
grow AV10 with glucose and increase the glycolysis flux for pyruvate synthesis. In our previous
study, addition of glucose was found to increase isobutanol production in Synechocystis 6803 136.
However in this study, when we grew the AV10 strain under mixotrophic conditions (with 5 g/L
glucose), it did not show a higher growth rate or display improvements in the final D-lactate titer
compared to the autotrophic condition. The AV10 cultures grown in the presence of glucose
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instead showed an impaired growth, possibly because the engineered pathways caused a
metabolic imbalance during glucose catabolism (Figure 5.3).
We also hypothesized that the intracellular pyruvate pool can be increased for lactate
production by addition of exogenous acetate. Supplementing cultures with acetate can redirect
more carbon from pyruvate to lactate in three possible ways 200: (1) acetate is used as a building
block for lactate production; (2) acetate provides additional carbon source for biomass synthesis
and reduce pyruvate consumption; (3) acetate conversion by acetyl-CoA synthetase consumes
Coenzyme-A (CoA), decreasing the CoA pool available for pyruvate decarboxylation. To test
this hypothesis, the AV10 cultures were supplemented with 15mM acetate. We found that
growth rate of the AV10 cultures with acetate (Figure 5.3A) remained comparable to their
growth rate under autotrophic condition, but there was substantial improvement in the synthesis
of D-lactate (the maximal titer reached 2.17 g/L and the peak productivity reached ~0.19
g/L/day, Figure 5.3B).
To further understand the role played by glucose and acetate in D-lactate synthesis, AV10
cultures were grown with [1,2-13C] glucose and [1,2-13C] acetate (Sigma, St. Louis). Cultures
were collected from the mid-log phase and were used for amino acid and D-lactate analysis. As
an example, mass spectrum of D-lactate from a cyanobacterial culture is shown in supplementary
Figure 5.7. The 13C abundance in the amino acids and lactate were obtained as mass fraction mi,
where ‘i’ indicates the number of 13C in the molecule. As can be seen from Figure 5.4A, glucosefed cells have significant

13

C-carbon distributed in amino acids (indicated by an increase in m1

and m2). Also, D-lactate from glucose-fed cultures was partially
isotopomer data in Figure 5.4A proved that

13

13

C-labeled (m2 ~0.22). The

C-glucose provided the carbon source for both

biomass and lactate production. However, glucose-based mixotrophic fermentation is not
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beneficial to D-lactate production compared to autotrophic cultures, possibly because carbon flux
from glycolysis may cause some carbon and energy imbalance136. As for the acetate-fed cultures,
only leucine and glutamate (which both use acetyl-CoA as their precursor) were significantly
labeled (an m2 of 0.31 and 0.32 respectively), while other amino acids (e.g., aspartate and
alanine) were nonlabeled (Figure 5.4B). Interestingly, D-lactate from acetate-fed culture was
almost nonlabeled, indicating that the carbons of lactate molecules were mainly derived from
CO2. Therefore, the observed enhancement of lactate synthesis in the presence of acetate can be
explained by two complementary mechanisms. First, acetate is an additional carbon source for
synthesizing biomass building blocks, such as fatty acids and some amino acids, thus redirecting
the extra carbon flux from CO2 to lactate. Secondly, acetate may limit the pyruvate
decarboxylation reaction by reducing the CoA pool by the formation of acetyl-CoA and thus
improve pyruvate availability for lactate synthesis.

5.3 Conclusions
The results reported here are for the autotrophic production of D-lactate in cyanobacteria
via the heterologous expression of a novel D-lactate dehydrogenase (GlyDH*) and by balancing
the precursors and cofactors. Other molecular strategies may also be applied to further improve
the D-lactate production: (1) by seeking stronger promoters 186; (2) optimizing ribosomal binding
sites

201

; (3) improving activity of GlyDH* via protein engineering; (4) introducing powerful

lactate transporter

202

; (5) knocking out competing pathways (such as the glycogen and

polyhydroxybutyrate synthesizing pathways); (6) duplicating the heterologous genes by
integrating at multiple sites

203

; and (7) limiting biomass production by knocking down the

pyruvate decarboxylation reaction. Also, considering the future outdoor algal processes for
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scaled up D-lactate production, we hypothesize that knocking out metabolic pathways that
synthesize carbon storage molecules (polyhydroxybutyrate and glycogen) may be deleterious to
algal growth during the night phase in day-night cultivation

204

. On the other hand, process

optimization by employing better light conditions, along with proper CO2 concentration, pH and
temperature control, may also be employed to increase the D-lactate productivity in a scaled-up
system.

5.4 Materials and methods
5.4.1 Chemicals and reagents. Restriction enzymes, Phusion DNA polymerase, T4 DNA ligase
and 10-Beta electro-competent E. coli kit were purchased from Fermentas or New England
BioLabs. Oligonucleotides were purchased from Integrated DNA Technologies (IDT). All
organic solvents, chemicals, 13C-labeled acetate, and glucose used in this study were purchased
from Sigma-Aldrich (St. Louis, MO).

5.4.2 Medium and growth conditions. E. coli strain 10-Beta was used as the host for all
plasmids constructed in this study. E. coli cells were grown in liquid Luria-Bertani (LB) medium
at 37°C in a shaker at 200 rpm or on solidified LB plates. Ampicillin (100 µg/mL) or kanamycin
(50 µg/mL) was added to the LB medium when required for propagation of the plasmids in E.
coli. The wild-type (glucose-tolerant) and the recombinant strain of Synechocystis 6803 were
grown at 30°C in a liquid blue-green medium (BG-11 medium) or on solid BG-11 plates at a
light intensity of 100 µmol of photons m-2s-1 in ambient air. Kanamycin (20 µg/mL) was added
to the BG-11 growth medium as required. Growth of the cells was monitored by measuring their
optical density at 730 nm (OD730) with an Agilent Cary 60 UV-vis spectrophotometer. 10 mL
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cultures for the synthesis of D-lactate were grown (initial OD730, 0.4) in 50 mL shake flasks
without any antibiotic and 1mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added for
induction. Mixotrophic cultures of Synechocystis 6803 were started in BG-11 medium containing
a known amount of glucose (0.5%) or acetate (15mM) as an organic carbon source.
5.4.3 Plasmid construction and transformation. The vector pTKA3 136 served as the backbone
for all the plasmids constructed in this study. The gene gldA101 encoding GlyDH*

190

, was

amplified from the plasmid pQZ115 with the primers gldA-o-F2 and gldA-o-R (Table 1 and 2).
The obtained 1.2 kb fragment was digested with BamHI/NheI and cloned into the same
restriction sites of pTKA3, yielding the vector pYY1. A gene cassette, which consists of the
codon optimized gldA101 (gldA101-syn) with the promoter Ptrc in the upstream and the
transhydrogenase (sth) gene from Pseudomonas aeruginosa

198

in the downstream, was

chemically synthesized by Genewiz Inc (South Plainfield, NJ) and cloned into the commonly
used E. coli vector pUC57-kan resulting in the plasmid vector pUC57-glda_sth. The vector
pUC57-glda_sth was digested with BamHI/NheI, and the yielding 2.6 kb fragment was cloned
into the corresponding restriction sites of pTKA3, resulting in the vector pDY2. The vector
pDY3 was constructed by self-ligation of the 8.2 kb fragment obtained through the digestion of
pDY2 with KpnI.

Natural transformation of Synechocystis 6803 was performed by using a double
homologous-recombination procedure as described previously

19

. Recombinant colonies

appeared between 7 and 10 days post inoculation. The genes of interest were finally integrated
into the psbA1 gene loci (a known neutral site under normal growth conditions) in the genome of
Synechocystis 6803

136

. For segregation, the positive colonies were propagated continuously
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onto BG-11 plates containing kanamycin and segregation of colonies was verified through a
colony PCR with the primers AMV17R and ps1_up_fwda (Table 1). The promoter and the
heterologous genes in the engineered strains were PCR amplified with respective primers (ptka3F, CO-F, O-F, sth-F) (Table 1) and sent for sequencing to Genewiz to verify the cloning
accuracy.

5.4.4 D (-) lactate analysis. D(-)/L(+) lactic acid detection kit (R-biopharm) was used to
measure the D-lactate concentration. Samples of the cyanobacterial culture (50 µL) were
collected every 3 days and centrifuged at 12,000 rpm for 5 min. The supernatant was collected
and the D-lactate concentration assay was performed following the manufacturer’s instruction.
All the reactions were performed in a 96-well plate reader at room temperature (Infinite 200
PRO microplate photometer, TECAN).
5.4.5 13C isotopomer experiment. To estimate the carbon contributions of glucose and acetate
for biomass and D-lactic acid synthesis a

13

C labeling experiment was performed. The mutant

AV10 was grown in a BG-11 medium with 0.5% glucose (1,2-13C2 glucose) or 15mM acetate
(U-13C2 acetate) (Sigma, St. Louis). Cultures were started at an OD730 of 0.4 and were grown
with labeled glucose or acetate for over 48 hours. The biomass samples and supernatant were
collected for measurement of lactate and amino acid labeling.

The proteinogenic amino acids from biomass were hydrolyzed and then derivatized with
TBDMS [N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide], as described previously
The derivatized amino acids were analyzed for their

13

160

.

C mass fraction by GC-MS (Hewlett

Packard 7890A and 5975C, Agilent Technologies, USA) equipped with a DB5-MS column
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(J&W Scientific) 160. The fragment [M-57]+ containing information of the entire amino acid was
used for calculating the

13

C mass fractions (M: the molecular mass of the derivatized amino

acids). The fragment [M-15]+ was used only for leucine, since its [M-57]+ overlaps with other
mass peak 205. To analyze extracellular D-lactic acid labeling, the supernatant (0.2 mL) was first
freeze-dried at -50 oC. The dried samples were then pre-derivatized with 200 µL of 2%
methoxyamine hydrochloride in pyridine for 60 minutes at 37 °C and then derivatized with 300
µL N-Methyl-N-(trimethylsilyl) trifluroacetamide (TMS) for 30 minutes at room temperature.
The natural abundance of isotopes, including

13

C (1.13%),

18

O (0.20%),

29

Si (4.70%) and

30

Si

(3.09%) changes the mass isotopomer spectrum. These changes were corrected using a published
algorithm and the detailed measurement protocol can be found in our previous paper 206.
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Table 5.1: Primer sequences
Primer name
gldA-o-F
gldA-o-F2

gldA-o-F3
gldA-o-R
gldA-o-R2
tranNADH-F
tranNADH-R
ptka3-F
CO-F
O-F
sth-F
AMV17R
ps1_up_fwda

Sequence (5’→ 3’)
GGATCCTTGACAATTAATCATCCGGCTCG
GGATCCTTGACAATTAATCATCCGGCTCGTATAATGTGTGGAATTGT
GAGCGGATAACAATTTCACACAGGAGATATAATCATATGACGAAAA
TCATTACCTCTCCAAGCAAGTTTATACAAGG
ATGACGAAAATCATTACCTCTCCAAG
GCTAGCTCATGCCCATTTTTCCTTATAATACCGCCCG
TTAGGCCCACTTTTCCTTGTAATAGC
CCTAAGCTAGCGGAGGACTAGCATGG
GCTAGCGGTACCTCAAAAAAGCCGG
CCCGAAGTGGCGAGCCCGAT
TTGATGTTGCCTTTGAACCC
ATGGATACGAAAGTGATTGC
GAGCTACCACCTGCGCAACA
GCGCGACTCCCCGTCTTTGACTATCCTTTTTAGGATGGGGCA
TACCGGAACAGGACCAAGCCTT
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Table 5.2: Plasmids and strains
Plasmids/Strains
pUC57-glda_sth
pQZ115
pTKA3
pYY1
pDY2
pDY3

E. coli 10-Beta
Synechocystis sp. PCC
6803
AV08
AV10

AV11

Description

Source or reference

Plasmids
Chemically synthesized gene cassette consisting
of Ptrc, gldA101-syn and sth.
Plasmid carrying gldA101
Backbone plasmid for all vectors constructed in
this study, with psbA1 as the integration loci.
Derived from pTKA3 with gldA101 and the
promoter, Ptrc.
Derived from pTKA3 with gldA101-syn, sth
and the promoter, Ptrc.
Derived from pTKA3 with gldA101-syn and the
promoter, Ptrc.
Strains
Cloning host strain.
Glucose tolerant wild type, naturally competent.
Synechocystis Ptrc::gldA101::Kmr, GlyDH*of
Bacillus.
Synechocystis Ptrc::(gldA101-syn)-sth::Kmr,
GlyDH* of Bacillus, transhydrogenase of
Pseudomonas.
Synechocystis Ptrc::gldA101-syn::Kmr, GlyDH*
of Bacillus.
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Genewiz; 190, 198 207
190
136

This study
This study
This study
New England
Biolabs
This study
This study
This study
This study

Figure 5.1A
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Figure 5.1B

Figure 5.1: Metabolic engineering of Synechocystis 6803 for the synthesis of D-lactic acid. (A)
Metabolic pathway for D-lactate synthesis. Lactate permeation through the cell membrane occurs
either via a lactate transporter or by passive diffusion202, 208. Red arrows indicate the
heterologous pathway engineered into Synechocystis 6803. Abbreviations: GlyDH*, mutant
glycerol dehydrogenase; TH, Transhydrogenase; 3PGA, 3-phosphoglycerate; CoA, Coenzyme
A; G1P, glucose 1-phosphate; F6P, fructose 6-phosphate; PHB, poly-β-hydroxybutyrate; RuBP,
ribulose 1,5-bisphosphate. (B) Colony PCR to verify the presence of the heterologous genes of
the mutant glycerol dehydrogenase (Left picture) and transhydrogenase (Right picture) in the
engineered strains of Synechocystis 6803. gldA101 was amplified with primers gldA-o-F3 and
gldA-o-R; gldA101-syn was amplified with primers gldA-o-F and gldA-o-R2; sth was amplified
with primers tranNADH-F and tranNADH-R (Table 5.1).
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Figure 5.2A

Figure 5.2B

Figure 5.2: Autotrophic production of D-lactate in the engineered strains of Synechocystis 6803.
(A) Growth curves and (B) D-lactate production in the engineered strains (n = 3). Circles: AV08
(with gldA101). Triangles: AV10 (with gldA101-syn and sth) and Squares: AV11 (with gldA101syn).
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Figure 5.3A

Figure 5.3B

Figure 5.3: Mixotrophic production of D-lactate by AV10. (A) Growth and (B) D-lactate
production in the engineered Synechocystis 6803 strain AV10 (n = 3), with the provision of
additional organic carbon source, i.e., with glucose and acetate (Mixotrophic metabolism).
Squares: with acetate. Circles: with glucose.
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Figure 5.4A
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Figure 5.4B

Figure 5.4: Isotopomer analysis showing the mass fraction of isotopomers for selected
proteinogenic amino acids [TBDMS based measurement] and D-lactate [MSTFA based
measurement]. Standard abbreviations are used for amino acids in the figure. (A) Cultures grown
with 5 g/L of [1,2-13C] glucose and (B) Cultures grown with 15 mM of [1,2-13C] acetate. “white
bar” m0 – mass fraction without any labeled carbon; “grey bar” m1 – mass fraction with one
labeled carbon; “black bar” m2 – mass fraction with two labeled carbon. (Note: natural 13C
makes up about 1.1% of total carbon as measurement background)
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Figure 5.5: Nuleotide sequence alignment of gldA101 and the codon-optimized gldA101 (i.e.,
gldA101-syn, synthesized by Genewiz Inc). Conserved nucleotide sequences in gldA101-syn are
indicated as dotted lines.
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Figure 5.6: Autotrophic growth curve for Synechocystis 6803 strains shows similar growth of
the engineered D-lactate producing strains as compared to the wild type strain. Diamond: Wild
type. Square: AV08. Triangle: AV10. Circle: AV11.

Figure 5.7: Mass spectra obtained via GC-MS confirm the presence of lactate in the cell culture
supernatant of AV10 strain. D/L lactate enzyme kit (R-Biopharm) was used to further confirm
that the product is an optically pure D-lactate.
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Chapter 6: Kinetic modeling and isotopic investigation of
isobutanol fermentation by two engineered Escherichia coli
strains
This chapter has been reproduced from the following publication:
Varman, A.M., Xiao, Y., Feng, X., He, L., Yu, H., & Tang, Y.J. Kinetic Modeling and Isotopic
Investigation of Isobutanol Fermentation by Two Engineered Escherichia coli Strains. Industrial
& Engineering Chemistry Research 51, 15855-15863 (2012).
AMV, YX, and XF contributed equally to this work.

Abstract
We constructed an E. coli BL21 strain with the Ehrlich pathway (the low performance
strain for isobutanol production). We also obtained a high isobutanol-producing E. coli strain
JCL260 from the James Liao group (University of California). To compare the fermentation
performances of the two engineered strains, we employed a general Monod-based model coupled
with mixed-growth-associated isobutanol formation kinetics to simulate glucose consumption,
biomass growth, and product secretion/loss under different cultivation conditions. Based on both
kinetic data and additional

13

C-isotopic investigation, we found that the low performance strain

demonstrated robust biomass growth in the minimal growth medium (20 g/L glucose), achieving
isobutanol production (up to 0.95 g/L). It utilized significant amount of yeast extract to
synthesize isobutanol when it grew in the rich medium. The rich medium also enhanced waste
product secretion, and thus reduced the glucose-based isobutanol yield. In contrast, JCL260 had
poor biomass growth in the minimal medium due to an inflated Monod constant (Ks), while the
rich medium greatly promoted both biomass growth and isobutanol productivity. With the
optimized keto acid pathway, JCL260 synthesized isobutanol mostly from glucose even in the
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presence of sufficient yeast extract. This study not only provided a kinetic model for scaled-up
isobutanol fermentation, but also offered metabolic insights into the performance tradeoff
between two engineered E. coli strains.
Key words: 13C-isotopic, Ehrlich pathway, mixed-growth-associated, tradeoff, yeast extract

6.1 Introduction
Biobutanols are second generation biofuels that have higher energy density and lower
water solubility than ethanol. Acetone-butanol-ethanol (ABE) fermentation is a traditional
bioprocess that uses Clostridium acetobutylicum to produce n-butanol, but such a process is
restrained by the slow alcohol production rate

209

. To overcome this restriction, the n-butanol

pathway derived from Clostridium has been reconstructed in fast-growing E. coli or yeast strains
23, 24, 118, 210

. Butanol biosynthesis via the Clostridium pathway has limitations including low

product titer and yield due to the accumulation of toxic metabolites. Another approach is via the
keto-acid pathway to produce low-toxicity isobutanol (IB), 25 where the amino acid biosynthesis
pathways and the Ehrlich pathway are incorporated for alcohol synthesis

26, 27

. This method

shows effective production of higher alcohols because of robust and ubiquitous amino acid
pathways.
Table 6.1 summarizes diverse biobutanol production strategies, including the
overexpression of the targeted pathway in different microbial hosts (including photoautotrophic
microbes), the elimination of competing pathways, the systems redesign of host metabolism, and
the integration of fermentation with in situ product separation. However, few papers have studied
the kinetics of engineered microbial hosts for biobutanol fermentation. To apply a newly
developed host in the biofuel industry, a kinetic-based model is of practical importance not only
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for designing optimal scaled-up fermentation, but also for understanding the internal metabolic
features of microbial hosts in responses to various nutrient sources and cultivation conditions. To
fulfill this gap, our lab has created an E. coli mutant that produces IB via the Ehrlich pathway.
Meanwhile, we have obtained a high performance E. coli strain JCL260 with an optimized
metabolism for IB synthesis (offered by the James Liao group)130. Based on fermentation data
using both strains, we developed an empirical model to analyze and compare their fermentation
kinetics. We also performed 13C-experiments to investigate the nutrient use of the two mutant
strains for the synthesis of biomass and IB.

6.2 Materials and Methods
6.2.1 Pathway construction
We engineered E. coli BL21 (DE3) by heterologous expression of Kivd (2ketoisovalerate decarboxylase) and AdhA (aldehyde reductase). The two genes were amplified
from Lactococcus lactis by PCR with high fidelity DNA polymerase Pfx (Invitrogen). Primers
for kivd:5’-gacactcgagtaatgtatacagtaggagattac-3’; 5’-tgcgggtaccttatgatttattttgttc-3’. Primers for
adhA:

5’-tcaactagtggtaccaggagatataatatgaaagcagcagtagtaagac-3’;

5’-

atttgcggccgcgcatgcttatttagtaaaatcaatgac-3’. The genes kivd (treated with XhoI / KpnI) and adhA
(treated with KpnI / SphI) were cloned into the pTAC-MAT-Tag-2 Expression Vector (SigmaAldrich) via XhoI / SphI to create the plasmid pTAC-KA, and then transformed into E. coli
BL21 (DE3). This low performance mutant used its native valine biosynthesis pathway to
generate 2-ketoisovalerate, and then converted it to IB by the heterologous Ehrlich pathway (Fig.
6.1). To confirm the expression of Kivd and AdhA, we performed SDS-PAGE analysis of the
recombinant strain and observed the protein bands of Kivd (~ 60 kDa) and AdhA (~ 35 kDa).
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The strain secreted IB, acetate, lactate, ethanol, and a small amount of n-propanol and methylbutanol (similar product profiles to other IB producing E. coli strains) 25. Additionally, Professor
James Liao from University of California offered us an E. coli strain JCL260 with plasmids
pSA65 and pSA69

211

. This high performance strain not only contains two plasmids that

overexpress the entire IB pathway, but also has gene deletions to interfere with waste product
(acetate, formate, ethanol, succinate, and lactate) biosynthesis.
6.2.2 Fermentation conditions
Fermentations were performed in a New Brunswick Bioflo 110 fermentor with a dissolved
oxygen (DO) electrode, a temperature electrode, and a pH meter. The 100% DO was defined as
the point where the cell-free medium was purged by air (~2 L/min) for 15 minutes. In the oxygen
limited fermentations (air rate = 0 L/min), the DO dropped to 0% during the exponential growth
phase. Two culture media were used: (a) a minimal medium that contained 2% glucose, M9 salts
(Difco), 10 mg/L vitamin B1, and 50 mg/L ampicillin; and (b) a rich medium containing the
minimal medium with 5 g/L yeast extract. To start each fermentation, 400 ml of culture was
inoculated with 5 ml of overnight LB culture (OD600~3) of the recombinant E. coli strain. The
cultivation conditions were: pH = 7.0 (controlled by adding 2 mol/L NaOH via an auto-pump),
temperature = 30 °C, and stirring speed = 200 rpm. For all fermentations, cells were first grown
in aerobic conditions (DO>50%) before adding 0.2 mM IPTG (Isopropyl β-D-1thiogalactopyranoside). Right after IPTG induction, we imposed two O2 conditions: 1) in aerobic
conditions, air (flow rate: ~1 L/min) was bubbled into the bioreactor to provide O2 and to remove
IB (i.e., gas stripping) from the bioreactor; 2) in O2 limited conditions, air was turned off and the
DO was maintained zero during IB production. For the low performance strain, we had three
fermentations: F1 (minimal medium and aerobic conditions), F2 (minimal medium and O2
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limited conditions), and F3 (rich medium and O2 limited conditions). For JCL260, we had two
fermentations (F4: minimal medium and aerobic conditions; F5: rich medium and aerobic
conditions).
6.2.3 Analytical methods for biomass and metabolites
Culture samples were taken after IPTG induction, ~3 ml of culture was taken from the
bioreactor at each time point for metabolite and biomass analysis. Biomass growth was
monitored by optical density OD600. There was a linear relationship between the dry cell weight
and OD600. To measure dry biomass weight, biomass samples were harvested by centrifugation,
washed with DI water, and dried at 100°C until their weight remained constant. Glucose,
ethanol, acetate, and lactate were measured using enzyme kits (R-Biopharm). Alcohols could be
detected using GC (Hewlett Packard model 7890A, Agilent Technologies, equipped with a DB5MS column, J&W Scientific) and a mass spectrometer (5975C, Agilent Technologies). The GCMS detected ethanol, IB, propanol and methyl-butanol. The IB concentration was determined by
a modified GC-MS method.
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Briefly, 400 µl of supernatant was extracted with 400 µl of

toluene (Sigma-Aldrich) by 2-min vortex, followed by high-speed centrifugation (16000×g). The
organic layer was taken for GC-MS analysis under the following program: hold at 70 °C for 2
min, ramp to 230 °C at 20 °C min-1, and then hold at 300 °C for 6 min. The carrier gas was
helium. The MS scan mode was from m/z 20 to 200. Samples were quantified relative to a
standard curve of IB concentrations for MS detection, and methanol was taken as an internal
standard.
6.2.4 13C-experiments for analyzing nutrient contributions to isobutanol productions
In the

13

C-experiments, the minimal medium with 2% fully labeled glucose (Cambridge

Isotope Laboratories) was supplemented with 1 g/L or 5 g/L yeast extract (Bacto). By measuring
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13

C-abundance in key metabolites from the engineered strains, we estimated the contribution of

yeast extract (non-labeled) to biomass and IB synthesis in the 13C-glucose medium. Specifically,
5 ml of cultures (with 13C-glcuose and yeast extract) were inoculated with 5 µl of overnight LB
culture of the engineered strain in a 50 ml falcon tube with a closed cap (shaking at 200 rpm,
30°C). The cultures (JCL260 or the low performance strain) were induced by 0.2 mM IPTG
(when OD600>0.2), and the samples were taken (at t=~24 hours, middle-log growth phase) for
isotopomer analysis of IB and amino acids. The two mass-to-charge peaks (m/z=74 for unlabeled
IB and m/z=78 for labeled IB) were quantified. Their ratio approximately corresponded to the
ratio of IB synthesized from unlabeled yeast extract vs. labeled glucose. Concurrently, we did
isotopic analysis of proteinogenic amino acids to identify the incorporation of unlabeled carbon
from yeast extract into biomass protein. The measurements were based on a GC-MS protocol,
using TBDMS (N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide, Sigma-Aldrich) to
derivatize hydrolyzed amino acids from the biomass

161

. The m/z ions [M-57]+ from

unfragmented amino acids were used for analysis except leucine and isoleucine. Because of
overlapping ions with [M-57]+, the [M-159]+ was used to calculate the isotopomer labeling
information of leucine and isoleucine 162.
6.2.5 Model formulation
We developed a kinetic model to describe the fermentation data after IPTG induction. The
model contained six time-dependent process variables: X, ACT, LACT, EtOH, IB, and Glu,
which represented the concentrations of biomass, acetate, lactate, ethanol, IB, and glucose,
respectively. The biomass growth model consisted of glucose-associated (RX) and yeast-extractassociated (RX,YE) terms. IB production was simulated by a mixed-growth-associated product
formation model (Eq. 6.5), where β was the non-growth associated IB production rate. In Eq.
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6.1~6.6, kd was the cell death rate; YAL was the acetate yield from lactate (equal to 0.67 g ACT/g
LACT, based on a 1:1 mol ratio); YXG, YAG, YEG, YLG, and YIG were the growth associated
glucose yields to biomass, acetate, ethanol, lactate, and IB. kIB was the removal rate of IB due to
gas stripping under aerobic fermentation F1, F4 and F5. In F2 and F3, IB loss was minimal (kIB
was set to zero). A first-order kinetic parameter (kact) was used to describe acetate production
from lactate.

dX
= R X − k d ⋅ X + R X ,YE
dt
dACT
= R A + YAL ⋅ k act ⋅ LACT ⋅ X
dt
dLACT
= RL − k act ⋅ LACT ⋅ X
dt
dEtOH
= RE
dt
dIB
= RIB + β ⋅ X − k IB ⋅ IB
dt
R
R
R
R
R
dGlu
= − X − A − E − L − IB
dt
YXG YAG YEG YLG YIBG

(6.1)
(6.2)
(6.3)
(6.4)
(6.5)
(6.6)

In Eq. 6.7~ 6.12, RX, RA, RE, RL, and RIB were the production rates of biomass, acetate, ethanol,
lactate, and IB from glucose, respectively.

RX =

µ max,app ⋅ Glu
K S + Glu

⋅

1
⋅X
ACT
1+
K iA

(6.7)

R A = α AX ⋅ R X

(6.8)

RE = α EX ⋅ R X

(6.9)

RL = α LX ⋅ R X

(6.10)

RIB = α IBX ⋅ R X

(6.11)

R X , YE = µ max,YE ⋅ e −kYE ⋅t X

(6.12)
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Rx represented a growth model with Monod constant KS and maximum specific rate coefficient
μmax,app. Since acetate inhibited E. coli growth by decreasing the intracellular pH, a noncompetitive inhibition KiA was included in the model

212

. The dependence of the glucose-based

growth rate on oxygen (i.e., aerobic growth vs. anaerobic growth) was implicitly included in the
calculation of μmax,app (i.e., the oxygen conditions affected μmax,app). αAX, αEX, αLX, and αIBX were
the growth-associated yields of acetate, ethanol, lactate, and IB, respectively. In the rich medium,
the yeast extract was quickly consumed to support biomass growth. The model included a yeastextract-associated biomass growth rate RX,YE using a two-parameter exponential decay function
Eq. 6.12. Table 6.2 summarized model parameters and their units.
For each batch culture, unknown parameters were determined by minimizing the sum of
the squares of the differences between the model’s predictions and the experimentally observed
growth and metabolite profiles
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. The “ode23” command in MATLAB (R2009a, Mathworks)

solved the differential equations, while the “fmincon” command searched suitable values of
parameters. To reduce the risk of having local solutions during the nonlinear parameter
estimation, we tested the initial guesses for 30 times within the range of possible values to
identify the global solution. To evaluate the quality of the parameter estimates, we checked the
sensitivity of the estimated parameters to the measurement inaccuracies. Fifty simulated
fermentation data sets (including both biomass and metabolite data) were generated by the
addition of normally distributed measurement noise to the fermentation data set (i.e., randomly
perturbed the measured data by 30%). The same data-fitting algorithm found new sets of
parameters. From the probability distribution of these parameter distributions, standard
deviations of model-fitted parameters were estimated.
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6.3 Results and discussion
6.3.1 Isobutanol fermentation results
In this study, both engineered E. coli strains employed the Ehrlich pathway (Fig. 6.1),
where 2-ketoisovalerate from valine metabolism is redirected to IB synthesis. For the low
performance strain, we simply over-expressed 2-ketoisovalerate decarboxylase and alcohol
dehydrogenase. For strain JCL260, both the Ehrlich pathway and 2-ketoisovalerate synthesis
pathway were overexpressed. This strain also had gene deletions involved in by-product
formation to increase pyruvate for IB synthesis, so it was reported to produce 22 g/L of IB in 112
hrs. 25
This study compared IB fermentation kinetics between the two strains.

For the low

performance strain, ethanol and lactate were barely detected in the aerobic conditions (Fig. 6.2).
IB titer only reached (0.2 g/L) in F1, because the in situ removal of IB was considerable (the
airflow carried IB out of the fermentor). Such gas stripping is an effective strategy to avoid the
IB accumulation in the culture that causes the inhibitory effect on alcohol production

211

. In O2

limited conditions, the F2 generated 0.95 g/L IB, 1.5 g/L ethanol, 2.2 g/L acetate, and 5.1 g/L
lactate, while the lactate was reused in the late fermentation stage (stationary growth phase).
With the addition of yeast extract, the F3 had fast biomass growth (Fig. 6.4). The cell density
reached a peak (2 g DCW/L biomass) after seven hours of IPTG induction, and glucose was
consumed within ~12 hours (compared to ~40 hours in the F1 and F2). The high rates for
biomass growth promoted IB production rate. It took the F3 15 hours to generate 0.6 g/L IB,
while it took F2 40 hours to generate same amount of IB. The addition of yeast extract also
resulted in a large amount of growth-associated organic acids (6.0 g/L lactate and 3.6 g/L
106

acetate), and thus decreased IB yield from glucose (0.7 g/L IB and 2.0 g/L ethanol from the F3).
A recent paper reported that JCL260 accumulated up to 7 g/L IB in an aerobic batch culture
using the culture media containing 55 g/L glucose, 2.2 g/L sodium citrate, 25 g/L yeast extract,
and complex trace metal solution

211

. This study performed two aerobic fermentations using

JCL260. In the complete minimal medium with 20 g/L glucose (F4, Fig. 6.5), JCL260 had very
slow biomass growth and low IB titer (~0.1 g/L). When yeast extract (5 g/L) was supplemented
(F5, Fig 6.6), IB productivity was significantly improved and its titer reached ~1 g/L (over
fivefold higher than the low performance strain). Meanwhile, JCL260 produced only 1 g/L
acetate (two times lower than the low performance strain) because of the deletion of
phosphotransacetylase (pta) 211.
6.3.2 Kinetic modeling of isobutanol fermentation
The same kinetic model simulated fermentation processes by two IB producers. Table 6.2 lists
the kinetic parameters obtained by nonlinear parameter fitting. For the low performance strain,
the specific growth rate μmax,app (0.015 h-1) in the oxygen limited conditions was lower than that
in the aerobic culture conditions (0.051 h-1). IB could be synthesized in both growth and
stationary phases. The O2 limited condition reduced growth associated IB yield, but promoted
non-growth associated IB production (e.g., β = 0.012 g IB/g biomass∙h in the F2). In the presence
of yeast extract, the yeast extract associated biomass growth rate (μmax,YE=0.48 hr-1) was one
order of magnitude higher than glucose-associated growth rates. The addition of yeast extract
(F3) also improved the biomass yield coefficient (YXG = 0.20) and the growth associated IB
production (αIBX = 0.78 g IB/g biomass). Meanwhile, the yeast extract increased yield
coefficients of waste products (YAG, YEG, YLG) in the F3. The IB yield coefficient YIG was 0.26 g
IB/g glucose under aerobic respiration, higher than YIG under O2 limited conditions (F2 and F3).
107

For JCL260, the fermentation data indicated that the strain had a highly inflated Monod constant
Ks (10 g/L), which caused the biomass growth rate to be slower than that of the low performance
strain. The slow growth led to poor IB synthesis in F4 (αIBX=0.06 g IB/g biomass). Because of
the knockout of the pta gene to reduce acetate synthesis, the growth associated acetate
production αAX in F4 was 0.35 g acetate/g biomass, suggesting that acetate production rate was
reduced compared to the low performance strain (αAX =0.62 g acetate/g biomass in the F1). On
the other hand, JCL260 still generated acetate after pta deletion

211

. The alternate acetate

pathways in JCL260 had higher glucose associated acetate yield (YAG) than that of the low
performance strain under aerobic conditions. This observation was consistent with the fact that
JCL260 (the strain with multiple gene knockouts) had a poor respiration rate, and thus higher
fraction of glucose was converted to biomass (i.e., YXG also increased) and byproducts rather
than degraded to CO2. When yeast extract was added to the growth media, the growth associated
IB production αIBX was 3.3 g IB/g biomass, which was about 5.7 folds higher than that of the low
performance strain. The addition of nutrients improved the JCL260 biomass growth, the cell
energy (such as NADH) generation, and the carbon flux through the IB pathway. In contrast, the
low performance strain had a suboptimal IB pathway. Therefore, yeast extract only enhanced
metabolic overflows to waste metabolites rather than improving IB titers (the F3).
Finally, the continuous flow of air into the bioreactor performed an in situ stripping of IB
out of the reactor in the aerobic conditions (F1, F4 and F5). Using the model, we estimated the
total IB production by JCL260 without any loss by gas stripping (i.e., kIB = 0, Fig. 6.6). The
model showed that the total IB could reach 5 g/L in F5. This result indicated that the IB
production can be significantly improved via the integration of IB fermentation with a
downstream product recovery process.
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6.3.3 Analysis of the role of yeast extract for isobutanol synthesis
Nutrient supplements plays important role in improving fermentation performance. Rich
media have been commonly used for butanol fermentations 25, 118, 214. In addition to providing the
building blocks for biomass growth, E. coli can also utilize the Ehrlich pathway to convert
protein hydrolysates to higher alcohols

215

. However, the contribution of rich nutrient (yeast

extract) to IB production was not quantified. Here, we used

13

C-experiments to determine the

ratio of carbon utilization from two different sources (nonlabeled yeast extract vs. fully labeled
13

C-glucose) under oxygen limited conditions via GC-MS analysis (Fig. 6.7). For the low

performance strain cultivation with 1 g/L yeast extract, its proteinogenic amino acids (e.g.,
histidine, leucine, isoleucine, lysine, and proline) were highly imported from exogenous amino
acids (>50%, corresponding to the 12C-dilutions), while IB was mostly labeled with four carbons
(m/z=78, IB came from labeled glucose). When excess yeast extract (5 g/L) was provided, the
low performance strain not only used yeast extract as the building blocks for cell growth, but
also converted it to IB (~50% IB was nonlabeled). On the other hand, with sufficient yeast
extract (5 g/L), JCL260 still mainly used 13C-glucose for IB production (labeled IB was > 90%).
In the rich media, JCL260 highly utilized yeast extract for biomass synthesis. It showed much
higher

13

C-labeling concentration (~20%) in valine than the low performance strain (~5%).

Higher abundance of

13

C-labeling in valine proved that the overexpression of the keto acid

pathway in JCL260 efficiently enhanced the

13

C-glucose flux towards 2-ketoisovalerate (the

common precursor for both IB and valine) and reduced the relative valine uptake from the rich
media.
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6.4 Concluding remarks
This study developed a general empirical model for IB fermentations by two engineered
E. coli strains. The model with nonlinear fitted parameters reasonably well described batch
fermentation data under denoted cultivation conditions. The model results indicated that the two
strains displayed a difference in biomass growth behavior and products generation. The
comparative study revealed the change of influential kinetic variables in responses to the
cultivation conditions. Moreover, we quantified the contribution of nutrient sources to product
yields via isotopic investigation, and proved that the keto-acid pathway was a rate-limiting step
for IB production in the low performance strain. This study may serve as a springboard for
developing useful bioprocess models for higher alcohols fermentations in the biotechnology
industry.
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Table 6.1: Recent studies on biobutanol production by engineered microorganisms
Products
IB

Substrate
Glucose

Host cell
E. coli

Titer
22 g/L

IB

Glucose

E. coli

50 g/L

IB

CO2

~0.4 g/L

IB

Cellulose

IB

Glucose

Synechococcus
elongatus
Clostridium
cellulolyticum
E. coli

IB

Glucose

E. coli

13.4 g/L

IB

Amino
acids

E. coli

~2 g/L

IB

CO2

~1 g/L

Butanol

Glucose

Ralstonia
eutropha
E. coli

Butanol

Galactose

2.5 mg/L

Butanol

Glucose

Saccharomyces
cerevisiae
E. coli

Butanol

Gluocse

E. coli

30 g/L

Butanol

CO2

Synechococcus
elongatus

14.5
mg/L

Butanol

Glucose

E. coli

~14 g/L

Utilization of a functional reversal of the betaoxidation cycle for the synthesis of alcohols
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Butanol

CO2

Synechococcus
elongatus

30 mg/L

Driving butanol synthesis pathway forward via an
engineered ATP consumption

175

0.66 g/L
1.7 g/L

1 g/L

4.6 g/L

Research Highlights
Introduction of a non-fermentative pathway to
produce IB; elimination of competing pathways to
reduce waste metabolite secretion
In situ IB removal from the bioreactor using gas
stripping
Overexpression of both non-fermentative pathway
and Rubisco for autotrophic IB production
Direct conversion of cellulose to IB using
engineered cellulolytic bacterial species
A strain optimized for IB production via
elementary mode analysis
Utilization of the NADH-dependent enzyme in
keto-acid pathway to alleviate co-factor imbalance
Utilization of protein hydrolysates for higher
alcohols synthesis by introducing enzymes for
exogenous transamination and deamination cycles
Developing an electromicrobial process to convert
CO2 to higher alcohols
A strain engineered for 1-butanol and 1-propanol
production via isoleucine biosynthesis pathway
Overexpression of n-butanol pathway derived from
Clostridium
Increase of the barrier for the reverse reaction of
butyryl-CoA to crotonyl-CoA via trans-enoyl-CoA
reductase
Use of trans-enoyl-CoA reductase and optimization
of NADH & acetyl-CoA driving forces
Anaerobic production of 1-butanol from CO2 using
CoA-dependent butanol pathway
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Table 6.2: Parameters of Monod model for E. coli IB fermentation
Notations
KS
KiA
μmax,app
YXG

Units

F1

F2

F3

F4

F5

Monod constant

g/L

0.32±0.05 a

0.32±0.05

0.32±0.05

10 ±1 c

10 ±1

Acetate inhibition

g/L

49±11 a

49±11

49±11

1.0 ± 0.2 c

Specific growth rate

0.051±0.004

0.015±0.001

0.18±0.03

1.0 ± 0.2
c

0.015±0.001

0.12± 0.01

0.12± 0.01

0.14±0.01

0.20±0.04

0.38±0.01

0.39±0.03

0.076±0.007

0.083±0.004

0.33±0.07

0.32±0.01

0.35±0.02

NA

0.26±0.01

0.40±0.05

NA

NA

NA

0.56±0.01

0.91±0.10

NA

NA

0.26±0.05

0.033±0.001

0.19±0.04

0.22±0.01

0.36±0.02

0.62±0.02

0.30±0.01

3.0±0.2

0.35±0.01

0.51±0.03

NA

3.7±0.2

4.0±0.2

NA

NA

NA

14±1

14±1

NA

NA

YAG

Acetate yield from glu

YEG

Ethanol yield from glu

YLG

Lactate yield from glu

YIG
αAX

IB yield from glu

g biomass/g
glu
g acetate/g
glu
g ethanol/g
glu
g lactate/g
glu
g IB/g glu

Growth associated
acetate synthesis
Growth associated
ethanol synthesis
Growth associated
lactate synthesis
Growth associated IB
synthesis
Cell death rate

g acetate/g
biomass
g ethanol/g
biomass
g lactate/g
biomass
g IB/g
biomass
/h

0.58±0.05

0.078±0.01

0.78±0.06

0.06±0.01

3.3±0.l

0.010±0.002

0.001±0.0002

0.010±0.001

0.02±0.01

0 ± 0.001

/h

0.11±0.02

NA

NA

0.11±0.01

0.11±0.01

NA

0.013±0.001

NA

NA

NA

NA

0.0034±0.00
02
0.55±0.03

NA

0.65±0.05

NA

NA

0.48±0.03

NA

0.32±0.03

0.002±0.002

0.012±0.001

0.006±0.0

0±0.0

0±0.0

αEX
αLX
αIBX
kd
kIB
kact

gas stripping rate

kYE
μmax,YE
β

Biomass yield from glu

/h

b

acetate production from
(h∙g
lactate
biomass/L)-1
Yeast extract
/h
consumption rate
Apparent specific
/h
growth rate with yeast
extract
Non-growth associated
g IB/
IB production
(g biomass∙h)

a): model assuming same values for F1, F2, and F3. b): model assuming same values for F2 and
F3. c): model assuming same values for F4 and the F5. NA: not applicable.
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Figure 6.1: Metabolism in the E. coli strains for IB production. RX, RX,YE, RA, RE, RL, and RIB
were shown in the Equations 6.1~6.12. IB synthesis consumes one mole NADPH (by keto-acid
reductoisomerase) and one mole NADH (by aldehyde reductase). The cell met metabolism
removes the redundant NADH by O2 oxidization or by synthesis of lactate and ethanol.
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Figure 6.2: Growth kinetics after IPTG induction (F1). The circles were experimental
measurements, and the solid lines were simulations from the Monod kinetic model (same as Fig.
6.3~Fig. 6.6).
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Figure 6.3: Growth kinetics after IPTG induction (F2).
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Figure 6.4: Growth kinetics after IPTG induction (F3, biomass growth data were from two
identical batch experiments).
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Figure 6.5: Growth kinetics after IPTG induction (F4).
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Figure 6.6: Growth kinetics after IPTG induction (F5).The dotted line was model prediction of
IB concentrations without gas stripping.
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119

Figure 6.7: The fraction of 13C carbon in metabolites from the low performance (A) and
JCL260 (B) IB-producing strains. The biomass was grown on fully labeled 13C-glucose, with 1
g/L (black bar) or 5 g/L (gray bar) nonlabeled yeast extract (n=2, GC-MS standard errors <
2%).The 13C fractions (R) of metabolites were based on the following equation:
1 n
R = ∑ (x ⋅ M X )
n X =0
where n was the total carbon number of the metabolite (0 ≤ x ≤ n). Mx was

the corresponding 13C isotopomer fraction for each isotopomer (M0 was unlabeled fraction, M1
was singly labeled fraction, M2 was doubly labeled fraction, etc.)
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Chapter 7: Conclusions and perspectives
7.1 Summary
With the advent of systems metabolic engineering, microbes have been engineered for
synthesizing numerous chemicals and biofuels. However, there are still several roadblocks that
remain to move microbial cell factories from laboratories to industry. In this thesis, we have
performed several studies to overcome difficulties associated with development of efficient
microbial platforms. In our first effort, we built a “Rule of Thumb” model to evaluate the various
variables that influence microbial performance for the biosynthesis of diverse products under
different growth conditions. Specifically, the yield of a microbial product remains difficult to
calculate either by using the reaction stoichiometry or by using the large scale metabolic models.
Filling this gap has been the focus for Chapter 2 and a statistical model was developed to get
production yield of chemicals in Saccharomyces Cerevisae. The developed statistical model
allows the user to get a priori yield value based on the engineering to be performed. The model
can also provide the degree of uncertainty associated with each parameter that can be used to
improve yield of a product. As a second effort, the use of

13

C isotopomer analysis to elucidate

the intrinsic product yields under complex nutrient conditions and multiple pathways for product
synthesis has been dischussed in Chapter 3. Moreover, in the same chapter we have also pointed
out the value of 13C-MFA in estimating the influence of microbial suboptimal energy metabolism
on final product yield.
Besides modeling based studies, metabolic engineering tools were also applied to create
three microbial platforms. Firstly, to contribute for the efforts in the field of biofuels and at the
same time to reduce the dependence on food based biofuels, isobutanol synthesis from carbon
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dioxide was demonstrated by engineering the cyanobacterium Synechocystis 6803. This research
work also established the need for process integration along with metabolic engineering to
improve microbial product titer. With the minimal engineering required for isobutanol synthesis,
via co-metabolism of extra carbon substrates, and by using an in situ isobutanol removal system,
we demonstrated improvements in isobutanol titer from the cyanobacterial platform. In the
course of this work, isobutanol was found to be degraded photo chemically in the presence of
hydroxyl radicals. This discovery necessitates research work for improvements in the reduction
of radical accumulation during cell cultivation and thereby to reduce product degradation. With
a view to offer industrial flexibility in handling carbon feedstock, mixotrophic fermentation was
performed for isobutanol synthesis by providing the cultures with glucose. The growth of the
strain did not increase as expected and the mechanism responsible for this counter action is likely
due to metabolic imbalance during mixotrophic isobutanol production and it needs further
investigation to elucidate the proper mechanism.
Secondly, the decreasing fossil fuel reserves will not only have its negative impact on the
fuels but also negatively impact the petrochemicals that we use. PLA has been proposed as a
substitute for polyethylene but presently its synthesis is food based. In Chapter 5, we have
engineered the cyanobacterium Synechocystis 6803 to synthesize D-lactic acid. We have also
demonstrated the positive effects of improving cofactor balance on the product titer along with
improvements in the carbon flux.

In this study, acetate was discovered to improve the

photoautotropic production of D-lactic acid by about two folds, possibly due to its inhibition of
pyruvate decarboxylation reaction. By incorporating various metabolic engineering techniques
and by feeding a cheap carbon feedstock, this work achieved the highest lactic acid titer ever to
be reported using cyanobacteria as a host. In addition, this study also guided us in identifying the
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target pathway (i.e., pyruvate decarboxylation) to improve microbial performance, which may be
potentially regulated by utilizing synthetic circuits that use either a growth associated or a light
activated promoter.
Thirdly, the kinetic models and the isotopomer studies developed in Chapter 6 allowed us
to compare the metabolic performance of the two strains. This work enabled us to compare the
role of nutrients in product synthesis between a low performance and a high performance strain,
and to identify the rate limiting section of the biosynthesis pathway. Overall this thesis elaborates
the combined application of isotopomer analysis, modeling and metabolic engineering research
to improve microbial product yields.

7.2 Challenges with commercialization of industrial biotechnology
With the need to develop a sustainable technology for resolving environmental concerns,
replacing fossil fuels and its derivatives, and creating new pharmaceutical chemicals for our
better living, numerous metabolic engineering works were performed in the past decade. Despite
the many successes that were attained in the laboratory, only a handful of them have reached
commercialization. Listed below are some key reasons for the failure of metabolic engineering
works to translate into microbial production at industrial scale 149:
1. Compared to chemical synthesis, both the rate and the yield of microbial biosynthesis are
very slow.
2. Substrate pretreatments are costly, reducing the profit margin for chemicals produced
from microbial cell factories. For example, microbial hosts are still not efficient enough
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in utilizing the low cost cellulose as their carbon feedstock, while the conversion of
cellulose into sugars is still commercially challenging.
3. Product purification is also expensive if the fermentation titers are low.
4. Contamination associated with bioprocesses can lead to huge loss in product yield, but
sterilization costs are very high.
5. Aerobic microbes need oxygen and the energy demand for intensive aeration makes
bioprocessing very expensive. Moreover, enormous amounts of fresh water are required
for fermentations.
6. Engineered strains are often unstable and therefore scaling up is very challenging.
7. Petroleum is still at an affordable price and therefore the profit margin for microbial
productions is still very limited.

Figure 7.1: Schematic diagram of the various factors that play a major role in the economic
feasibility of a biofuel production process.
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In the past decade, several lessons were learnt from the biofuel industry and it cautions us
that commercialization of biofuel production technology is a difficult task. Thereby,
industrializing biofuel production would need the combined expertise of biologists, chemists,
and engineers for its success. In order to reduce the cost of biofuel production, consolidated
bioprocessing (remove the pretreatment step and integrated fermentation with bio-separation)219
and co-production of value added products with biofuels are two key approaches in addition to
metabolic engineering of microbial platforms (Figure 7.1). Moreover, global economy and
government policy also influence the direction of biofuel industry. Therefore, we believe that
engineering microbes for producing biofuels or other value-added chemicals is a promising
direction that would require many years of hard work to realize its true potential.

7.3 Challenges with cyanobacterial bioprocessing
Metabolic engineering for the synthesis of value added products from cyanobacteria looks
attractive as they can utilize carbon dioxide and sunlight. There are two main roadblocks for
commercializing a technology that synthesizes products from engineered cyanobacteria. The
first roadblock is related with cyanobacterial cultivation in large-scale. In large scale,
cyanobacteria cultures are proposed to be grown either in open ponds or in closed photobioreactors. Although open pond are cheap for operation, they require year round sunlight as
well as a warm climate, placing a strong limitation on the geographical location. Open ponds
also have the other disadvantage of water loss by evaporation and a huge risk of microbial
contamination. On the other hand, closed bioreactors looks like a good alternative, but they are
still very expensive to operate

220

. Algal photo-bioreactors also often suffer from higher
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maintenance costs due to the formation of bio-films that block light penetrations. The second
roadblock is associated with the low rates and titers of product synthesis in engineered
cyanobacteria compared to their heterotrophic cousins. For example, an E. coli strain produced
5.2 g/L of fatty acids in 3 days

221

, whereas the highest fatty acid titer in cyanobacteria was

below 0.2 g/L after 2-weeks of cultivation

172

. Similarly, engineered Synechocystis 6803

achieved only 0.2 mg/L fatty alcohol, a 3000 fold lower titer as compared to the levels achieved
by engineered E. coli (0.6 g/L)

222, 30

. Cyanobacterial biosynthesis often takes weeks to

synthesize a chemical in reasonable titers and this increases the operation along with
maintenance costs. Long fermentations may also lead to product degradation and microbial
contamination 136, further reducing the profit margin.
To overcome the cost due to the low productivity from cyanobacterial biofactories, we
have proposed the integration of wastewater treatment with bio-production of D-lactate in our
future research work. We believe that, the natural ability of cyanobacteria in utilizing N and P
from wastewater along with its potential to synthesize value-added chemical synthesis from CO2
using sunlight would result in a commercially viable process technology. Besides, strict lifecycle-analysis needs to be performed to reveal the energy, water and environmental impacts from
these phototrophic microbial platforms 223.

7.4 Recent developments in synthetic biology
Development of engineered microbes for artemisinic acid (precursor to the antimalarial
drug artemisinin) production has been one of the major success stories since the inception of
metabolic engineering 78. Towards developing a strain capable of synthesizing artemisinic acid
at industrial levels

224

, it has been quoted that very little time and money were focused on
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identifying the right metabolic pathways. The rest of the efforts were focused on applying the
various synthetic biology tools to iteratively improve the performance of the strain 225. Synthetic
biology was utilized to improve the production levels by carefully coordinating the expression of
multiple genes to reduce intermediates accumulation, by balancing cofactors and by enriching
precursors.

Thereby, synthetic biology tools along with systems analysis and metabolic

modeling can significantly speed up pathway optimization and strain development.
In recent studies, synthetic biology has extensively been applied for balancing metabolic
pathways to increase the performance of the engineered microbes 226. The simplest strategy was
to engineer cells by employing different promoters of varying strength and this has been
successful on numerous occasions150, 227, 228. Balancing the expression of all genes in a pathway
can also be achieved by manipulating at mRNA level. This can be accomplished by varying the
stability of specific mRNA segments that code for the enzyme

12

, by designing synthetic

ribosome binding sites 229 and by utilizing transcription factor based approach to reprogram gene
transcription at global level

85

. Metabolite channeling to improve product yield has also been

performed to improve performance by utilizing synthetic protein scaffolds

230, 231

. Moreover,

dynamic sensor-regulator systems have been developed to overcome toxicity of intermediates by
switching the pathway at the correct time and thereby increasing the overall performance

110

.

Finally, high throughput genome engineering are being developed to speed up the creation of
optimal hosts. For example, multiplexed automated genome engineering (MAGE), a strategy for
large scale reprogramming of the genome based on natural selection principles may accelerate
metabolic engineering by effectively tuning the expression of multiple genes

232

. In addition,

trackable multiplex recombineering (TRMR) can create and evaluate thousands of genetic
modifications simultaneously 233.
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7.5 Future directions
Overall, there are still many challenges associated with developing industrial-strength strains for
the synthesis of chemicals. However, several opportunities do exist to make microbial processes
to be competitive with chemical synthesis. Along with developing more powerful synthetic
biology tools, research must also focus on developing cost effective technologies to overcome
challenges mentioned in Chapter 7.2. Thereby, microbial cell factories should be engineered to
metabolize multiple substrates, synthesize multiple products, reduce byproducts, and to minimize
oxygen demand as well as to engineer them with control systems to uptake key precursors and
synthesize products as needed. All these engineering must be performed in an integrated manner
with a systems level understanding of the cell at all levels (Figure 7.2). Systems level analysis
will enable researchers to identify bottleneck pathways and genes that can be targeted for
improved performance. Model development to simulate the output of synthetic biology tools
would enable us to predict and understand the dynamics of engineered pathways.

This

development would lead to a tremendous reduction in experimental hours by screening for
optimal pathway designs on a computer, before engineering it into a host cell. Also, to improve
the economical margin of cyanobacterial based product synthesis, the engineered algal process
can be integrated with a wastewater treatment facility. On the other hand, our incomplete
knowledge about the biology of the cell often requires guesses to perform metabolic engineering.
As our understanding about the cell grows, guesswork based experiments would be avoided
leading to more successful outcomes. Simultaneously, we have to work with process engineers
to bridge gaps between laboratories studies and industrial applications. With all these
128

developments, it is possible that in the near future, we may realize the dream of using microbial
cell factories for the production of diverse value-added chemicals at industrial scale from
cheaper feedstock.

Figure 7.2: Schematic diagram of an integrated iterative approach required for the development
of high-performance microbial strains towards industrial commercialization.
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for the production of chemicals and fuels.” 11th Workshop on Cyanobacteria, 2013, MO.
• Varman AM, Xiao Y, Pakrasi HB, Tang YJ. “Metabolic engineering of the cyanobacterium
Synechocystis 6803 for isobutanol biosynthesis.” Indo - US Workshop on Cyanobacteria, 2012,
Lonavala, India.
• Varman AM, Chen A, Wu SG, Xiao Y, Yi Y, Le Y, Kang C, Tang YJ. “Advanced biofuel
production from organic wastes.” 4th International Symposium on Energy and Environment, 2012,
Mumbai, India.
• Varman AM, Xiao Y, Pakrasi HB, Tang YJ. “Metabolic engineering of the cyanobacterium
Synechocystis 6803 for isobutanol biosynthesis.” 4th International Symposium on Energy and
Environment, 2012, India.
• Varman AM, Xiao Y, Pakrasi HB, Tang YJ. “Metabolic engineering of the cyanobacterium
Synechocystis 6803 for isobutanol biosynthesis.” Annual Mid-American Environmental
Engineering Conference, 2012, IL.
• Varman AM, Xiao Y, Pakrasi HB, Tang YJ. “Metabolic engineering of the cyanobacterium
Synechocystis 6803 for isobutanol biosynthesis.” Plant Biology Annual Retreat, 2012, October 19,
Eureka, MO.
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• Varman AM, Xiao Y, Nguyen A, Pakrasi HB, Tang YJ. “Metabolic engineering of the
cyanobacterium Synechocystis 6803 for isobutanol biosynthesis.” The 112th ASM General
Meeting, 2012, San Francisco, CA.
• Xiao Y, Feng X, Yu H, Varman AM and Tang YJ. “Kinetic modeling of isobutanol fermentation
by recombinant Escherichia Coli.” The 2011 AIChE Annual Meeting, 2011, October 16-21,
Minneapolis, MN
• Varman AM, Xiao Y, Feng X, et.al. “Statistics-based model for prediction of chemical
biosynthesis yield from Saccharomyces cerevisiae and E. coli.” The 111th ASM General Meeting,
2011, LA.
TEACHING EXPERIENCE
• Teaching assistant, ChE 351 - Engineering Analysis of Chemical Systems, WUSTL.
• Teaching assistant, ChE 367 - Transport Phenomena I, WUSTL.
• Teaching assistant, EECE 595 - Energy and Buildings, WUSTL.
• Teaching assistant, CL 253 - Chemical Engineering Thermodynamics, IIT Bombay.
• Teaching assistant, CL 610 - Experimental methods, IIT Bombay.
• Mentored graduate and undergraduate students at Washington University and IIT Bombay.
AFFILIATIONS
• American Chemical Society.
• American Institute of Chemical Engineers.
INDUSTRIAL EXPERIENCE
Scientific Officer C, Bhabha Atomic Research Centre, Mumbai, India (June 2006 – July 2008).
• Performed research as well as designed extraction equipment, air lift pumps and tanks in utility
section.
• Analyzed and prepared the safety report for an ongoing plant erection and commissioning project.
• Supervised the on-site plant erection and commissioning.
Process Engineer, Shasun chemicals and drugs, Pondicherry, India (May – July 2003)
• Provided optimization and trouble-shooting support for plant operations.
• Supervised, monitored and reported plant performance on a regular basis.
ADDITIONAL SKILLS
Software Packages: MATLAB, R, GAMS, HYSYS, Foxpro, HENS, Mathematica, AutoCAD.
Programming Languages: C, C++, Pascal, FORTRAN, Perl.
Spoken/Written: English, Tamil, Telugu, Hindi.
Others: Senior in Typewriting.
ACTIVITIES
• Initiated and organized students’ monthly meetings for the metabolic engineering cluster at
WUSTL.
• Lead a team of students to prepare a departmental video at WUSTL.
• Performed in a skit at Washington University in St. Louis.
• Active member of World Wildlife Fund (WWF).
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